Industry Events Board (pharmaceutics and related)
This board records and monitors material events occurred in United States(US), Europe(EU), and Canada(CA) -- reported by companies in the industries including
pharmaceuticals(n=652), biological products (diagnostic and non diagnostic)(n=188), commercial physical/biological research or service(n=19).
For US, this board tracks status of interventional clinical trials submitted to ClinicalTrials.gov, FDA Human/Animal drugs submission, tentative approval, and marketing status, as well as CBER approved biological products. For EU, it tracks Europe Medicines Agency (EMA) regulated Human/Animal drugs marketing, and summary of opinion. For CA, it tracks Human/Animal drugs marketing and approval regulated by Canadian Food Inspection Agency (CFIA) and Health Canada.
This board provides powerful sorting strategies to help investors find, for example, companies with the most recent drug marketing in specific country/area, or with most approvals in specific year, or with research focus in specific disease condition(s). The information are presented together with Simple Moving Average (SMA) thumbnail chart and links to insider tradings and institutional holdings. For each company, there is also a standalone webpage describing the details of clinical trials and a list of drugs that are approved/marketed.
Sort Results
by US clinical trial count (largest first):
| Year: | Recruitment Status: | Phase: |
by US clinical trial focus of disease condition(s):
| Status(es): | Phase(s): |
Show Other Sort/Display Options
by US FDA submission count (largest first):
| Year: | Type: |
by US FDA submission time (latest first):
| Type(s): |
by US drug marketing count (largest first):
| Year: | Scope: | Status: |
by EU drug marketing count (largest first):
| Year: | Scope: | Status: |
by CA drug marketing count (largest first):
| Year: | Scope: | Status: |
by US drug marketing time (latest first):
| Scope(s): | Status(es): |
by EU drug marketing time (latest first):
| Scope(s): | Status(es): |
by CA drug marketing time (latest first):
| Scope(s): | Status(es): |
Display Options
| Force Include Symbol (pharmaceutics and related company): |
||
| Historical Years: | Clinical Trial Status(es): | Clinical Trial Phase(s): |
| Thumbnail SMA: | SMA Years: | |
| Max Records Number: |
Instructions
Only one sorting strategy will be applied for each query. When no checkbox is selected, default is "by US clinical trial count".
Count related sort: (e.g. by US clinical trial count; by US FDA submission count) orders results descendingly by the number of matched records.
Time related sort: (e.g. by US FDA submission time; by US drug marketing time) orders results by the most recent update time. For each option, when multiple categories are selected (e.g. both Phase 1 and Phase 2 are selected), the sorting will be based on the most recent update in either category, whichever contains the latest update.
US clinical trial focus of disease condition(s): select one or more disease conditions from the left box and move to the right box. The search results will be sorted based on relevence to condition(s) appearred in the right box.
Clinical trial recruitment statuses: simplified to 4 major categories according to the original statuses appearred in interventional studies on ClinicalTrails.gov.
Ongoing: Active, not recruiting; Enrolling by invitation; Recruiting; Not yet recruiting
Finished: Completed
Abnormal: Unknown status; Suspended
Aborted: Terminated; Withdrawn
Clinical trial phases: simplified to 5 major categories according to the original phases used by ClinicalTrails.gov
Phase 1: Early Phase 1; Phase 1
Phase 2: Phase 1|Phase 2; Phase 2
Phase 3: Phase 2|Phase 3; Phase 3
Phase 4: Phase 4
Phase NA: All other scenarios
US FDA submission types
Type 1: Type 1 - New Molecular Entity; Type 1 - New Molecular Entity and Type 4 - New Combination
Type 2: Type 2 - New Active Ingredient; Type 2 - New Active Ingredient and Type 3 - New Dosage Form; Type 2 New Active Ingredient and Type 4 New Combination
Type 3: Type 3 - New Dosage Form; Type 3 - New Dosage Form and Type 4 - New Combination
Others: All other scenarios
US, EU, CA drug marketing status
US drugs scope "Bioproduct" contains biological products that are approved by the Center for Biologics Evaluation and Research (CBER).
US drugs status "Tentative Approval": granted by the FDA if an abbreviated new drug application(ANDA) meets the substantive requirements for approval but cannot obtain final approval due to unexpired patents or exclusivities.
Europe drugs status "positive": summary of opinion published by European Medicines Agency (EMA) based on the CHMP's or CVMP's positive or negative recommendation. This summary is replaced by a full European public assessment reports once the European Commission has decided - taking the EMA opinion into consideration - whether to grant the marketing authorisation.
Drug products with same active ingredient but different forms or dosage strengthes are counted only once
Force include symbols
Add trading symbols for any pharmaceutics related company. The corresponding records will be forced to be displayed at the begining of the retrieved results. The force included records have lightgreen background.
Result Table Explained
Clinical trail count: the number of clinical trials started in corresponding year.
FDA submissions: the number of "ORIGINAL" (i.e. Supplementary not considered) FDA submissions in corresponding year.
⬤ latest update ≤ 7 days
⬤ latest update ≤ 30 days
⬤ latest update ≤ 90 days
Data last updated 2023-12-06 23:25:06 -0600 US CDT
US Clinical Trials and FDA Submissions
| Symbol | SMA (50w/20w/10w/5w / 50d/20d/10d/5d) | Research Focus | Year | Clinical Trials Count | US FDA submissions | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ongoing | |||||||||||
| Phase 1 | Phase 2 | Phase 3 | Phase 4 | Type 1 | Type 2 | Type 3 | Others | ||||
|
AZN
(AstraZeneca PLC) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(17) Carcinoma, Non-Small-Cell Lung(8) Breast Neoplasms(6) Fatty Liver(5) Liver Diseases(4) Non-alcoholic Fatty Liver Disease(4) Lung Neoplasms(3) COVID-19(2) Overweight(2) Crohn Disease(2) Neurofibroma, Plexiform(2) (skip...) Phase 1:Finished: Diabetes Mellitus, Type 2(58) Neoplasms(54) Diabetes Mellitus(25) Pulmonary Disease, Chronic Obstructive(23) Lung Diseases, Obstructive(22) Carcinoma, Non-Small-Cell Lung(15) Arthritis(14) Arthritis, Rheumatoid(13) Alzheimer Disease(13) Asthma(12) Breast Neoplasms(12) (skip...) Phase 1:Aborted: Neoplasms(11) Diabetes Mellitus, Type 2(4) Pulmonary Disease, Chronic Obstructive(4) Leukemia, Myeloid, Acute(4) Leukemia, Myeloid(4) Lymphoma(4) Lung Diseases, Obstructive(3) Leukemia(3) Heart Failure(2) Breast Neoplasms(2) Diabetes Mellitus(2) (skip...) Phase 2:Ongoing: Carcinoma, Non-Small-Cell Lung(19) Lung Neoplasms(17) Neoplasms(9) Lymphoma(7) Breast Neoplasms(6) Carcinoma(5) Ovarian Neoplasms(5) Fibrosis(4) Non-alcoholic Fatty Liver Disease(4) Fatty Liver(4) Adenocarcinoma(4) (skip...) Phase 2:Finished: Lung Diseases, Obstructive(30) Pulmonary Disease, Chronic Obstructive(29) Diabetes Mellitus(29) Breast Neoplasms(28) Diabetes Mellitus, Type 2(28) Lung Diseases(25) Asthma(25) Prostatic Neoplasms(14) Carcinoma, Non-Small-Cell Lung(12) Lung Neoplasms(11) (9) (skip...) Phase 2:Abnormal: Kidney Neoplasms(1) Carcinoma, Renal Cell(1) Carcinoma(1) Phase 2:Aborted: Arthritis, Rheumatoid(5) Arthritis(5) Carcinoma, Non-Small-Cell Lung(5) Lung Neoplasms(5) Pulmonary Disease, Chronic Obstructive(3) Lung Diseases(3) Depression(3) Depressive Disorder(3) Diabetes Mellitus, Type 2(3) Colorectal Neoplasms(3) Neoplasms(3) (skip...) Phase 3:Ongoing: Carcinoma, Non-Small-Cell Lung(26) Lung Neoplasms(22) Breast Neoplasms(19) Carcinoma(13) Asthma(10) Pulmonary Disease, Chronic Obstructive(8) Lung Diseases, Obstructive(8) Lung Diseases(8) Carcinoma, Hepatocellular(6) Prostatic Neoplasms(5) Carcinoma, Ovarian Epithelial(5) (skip...) Phase 3:Finished: Asthma(97) Diabetes Mellitus, Type 2(96) Diabetes Mellitus(87) Pulmonary Disease, Chronic Obstructive(44) Lung Diseases, Obstructive(44) Lung Diseases(37) Hypercholesterolemia(25) Depressive Disorder(23) Depression(23) Disease(18) Breast Neoplasms(17) (skip...) Phase 3:Abnormal: Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Diabetes Mellitus, Type 2(1) Diabetes Mellitus(1) Phase 3:Aborted: Diabetes Mellitus, Type 2(14) Schizophrenia(4) Diabetes Mellitus(4) Alzheimer Disease(3) Asthma(3) Crohn Disease(2) Anemia, Sickle Cell(2) Dementia(2) Breast Neoplasms(2) Mental Disorders(2) Psychotic Disorders(2) (skip...) Phase 4:Ongoing: Asthma(3) Hyperkalemia(2) Carcinoma, Non-Small-Cell Lung(2) Pulmonary Eosinophilia(1) Prostatic Neoplasms(1) Renal Insufficiency, Chronic(1) Kidney Diseases(1) Heart Failure(1) Lung Neoplasms(1) Phase 4:Finished: Diabetes Mellitus, Type 2(23) Diabetes Mellitus(22) Gastroesophageal Reflux(21) Asthma(17) Pulmonary Disease, Chronic Obstructive(15) Lung Diseases, Obstructive(13) Lung Diseases(11) Schizophrenia(9) Esophagitis, Peptic(7) Heartburn(6) Breast Neoplasms(6) (skip...) Phase 4:Aborted: Diabetes Mellitus, Type 2(3) Diabetes Mellitus(3) Hypercholesterolemia(3) Bipolar Disorder(3) Prostatic Neoplasms(2) COVID-19(1) Hyperkalemia(1) Pneumonia(1) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases, Obstructive(1) Lung Diseases(1) (skip...) Phase Not Applicable:Ongoing: Asthma(1) Phase Not Applicable:Finished: Asthma(4) Hyperlipidemias(1) Dyslipidemias(1) Hypertension(1) Infarction(1) Myocardial Infarction(1) Carcinoma, Non-Small-Cell Lung(1) Lung Neoplasms(1) Cardiovascular Diseases(1) Peripheral Vascular Diseases(1) Peripheral Arterial Disease(1) (skip...) |
ALL | 63 | 82 | 139 | 10 | 29 | 3 | 18 | 30 |
| 2023 | 19 ⬤ | 19 ⬤ | 30 ⬤ | 1 | 2 ⬤ | - | - | 2 | |||
| 2022 | 13 ⬤ | 16 ⬤ | 23 ⬤ | 4 ⬤ | 1 | - | 1 | 1 | |||
| 2021 | 1 | 12 ⬤ | 28 ⬤ | 1 ⬤ | 2 | - | - | - | |||
|
MRK
(Merck & Company Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(7) Renal Insufficiency(3) Kidney Failure, Chronic(3) Prostatic Neoplasms(2) Schizophrenia(2) Kidney Diseases(2) Hematologic Neoplasms(2) Liver Diseases(2) (2) Carcinoma, Renal Cell(2) Carcinoma(2) (skip...) Phase 1:Finished: Diabetes Mellitus, Type 2(39) Hepatitis C(32) Diabetes Mellitus(28) Neoplasms(27) Hepatitis(26) Renal Insufficiency(23) Hypertension(22) Hepatitis A(18) HIV Infections(14) Liver Failure(12) Hepatic Insufficiency(12) (skip...) Phase 1:Aborted: Neoplasms(13) Hepatitis(5) Hepatitis C, Chronic(5) Hepatitis C(5) Leukemia, Myeloid(5) Leukemia(5) Hepatitis A(4) Renal Insufficiency(4) Precursor Cell Lymphoblastic Leukemia-Lymphoma(4) Leukemia, Myelogenous, Chronic, BCR-ABL Positive(3) Hematologic Neoplasms(2) (skip...) Phase 2:Ongoing: Carcinoma(13) Neoplasms(11) Lymphoma(9) Carcinoma, Renal Cell(6) Carcinoma, Non-Small-Cell Lung(6) Melanoma(5) Lung Neoplasms(4) Hodgkin Disease(4) Lymphoma, B-Cell(4) Esophageal Neoplasms(3) Hypertension(3) (skip...) Phase 2:Finished: Hepatitis(31) Hepatitis C(31) Hepatitis A(29) Hepatitis C, Chronic(24) Infections(19) Carcinoma(15) Diabetes Mellitus, Type 2(13) Breast Neoplasms(13) Carcinoma, Non-Small-Cell Lung(13) HIV Infections(13) Communicable Diseases(12) (skip...) Phase 2:Abnormal: HIV Infections(4) Phase 2:Aborted: Carcinoma, Non-Small-Cell Lung(9) Diabetes Mellitus, Type 2(8) Neoplasms(8) Diabetes Mellitus(7) (6) Hepatitis C(5) Hepatitis A(5) Lung Diseases(5) Hepatitis(4) Syndrome(4) Infections(4) (skip...) Phase 3:Ongoing: Carcinoma(21) Carcinoma, Non-Small-Cell Lung(17) Lung Neoplasms(17) Papillomavirus Infections(8) Infections(7) Carcinoma, Renal Cell(7) Prostatic Neoplasms(6) Carcinoma, Squamous Cell(6) Melanoma(6) Hypertension(5) Familial Primary Pulmonary Hypertension(5) (skip...) Phase 3:Finished: Diabetes Mellitus, Type 2(72) Diabetes Mellitus(71) Hepatitis(46) Hepatitis A(45) Hepatitis C(36) Hepatitis C, Chronic(30) Infections(28) Pneumococcal Infections(27) Communicable Diseases(23) Herpes Zoster(22) Papillomavirus Infections(18) (skip...) Phase 3:Abnormal: Papillomavirus Infections(1) Phase 3:Aborted: Diabetes Mellitus, Type 2(13) Hepatitis(10) Hepatitis A(10) Hepatitis C(9) Hepatitis C, Chronic(7) Dyslipidemias(6) Diabetes Mellitus(6) Hypercholesterolemia(5) Hepatitis, Chronic(3) Herpes Zoster(3) Osteoporosis(3) (skip...) Phase 4:Ongoing: Sclerosis(1) Multiple Sclerosis(1) Squamous Cell Carcinoma of Head and Neck(1) Carcinoma, Squamous Cell(1) Carcinoma(1) Melanoma(1) Carcinoma, Non-Small-Cell Lung(1) Phase 4:Finished: Sclerosis(9) Multiple Sclerosis(9) Diabetes Mellitus, Type 2(7) Diabetes Mellitus(7) Hepatitis(7) Infections(7) Hypertension(6) Hepatitis A(6) Vomiting(6) Nausea(6) Spondylitis(5) (skip...) Phase 4:Aborted: Hepatitis(8) Hepatitis A(8) Hepatitis C(7) Hepatitis C, Chronic(6) Infertility(4) Psoriasis(3) Diabetes Mellitus, Type 2(2) Diabetes Mellitus(2) Spondylitis, Ankylosing(2) Spondylitis(2) Breast Neoplasms(2) (skip...) Phase Not Applicable:Finished: HIV Infections(6) Osteoporosis(4) Diabetes Mellitus, Type 2(2) Diabetes Mellitus(2) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases(1) Glucose Intolerance(1) Hyperglycemia(1) Insulin Resistance(1) Hypertension(1) Asthma(1) (skip...) Phase Not Applicable:Aborted: Multiple Myeloma(1) |
ALL | 40 | 72 | 133 | 3 | 41 | 6 | 33 | 26 |
| 2023 | 11 ⬤ | 9 ⬤ | 21 ⬤ | - | - | - | - | - | |||
| 2022 | 9 ⬤ | 12 ⬤ | 18 ⬤ | - | - | - | - | - | |||
| 2021 | 9 ⬤ | 20 ⬤ | 29 ⬤ | 1 ⬤ | 2 | - | - | 1 | |||
|
NVS
(Novartis AG) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Carcinoma, Non-Small-Cell Lung(8) Melanoma(6) Carcinoma(5) Colorectal Neoplasms(5) Glioblastoma(4) Lymphoma(4) Lymphoma, Non-Hodgkin(3) Neoplasms, Plasma Cell(3) Multiple Myeloma(3) Leukemia(3) Carcinoma, Renal Cell(3) (skip...) Phase 1:Finished: Neoplasms(51) Breast Neoplasms(26) Liver Diseases(22) Renal Insufficiency(17) Lymphoma(14) Multiple Myeloma(11) Leukemia(11) Neoplasms, Plasma Cell(10) Leukemia, Myeloid(10) Carcinoma, Non-Small-Cell Lung(9) Lung Neoplasms(9) (skip...) Phase 1:Aborted: Neoplasms(11) Leukemia(7) Carcinoma, Non-Small-Cell Lung(5) Leukemia, Lymphoid(5) Colorectal Neoplasms(4) Lung Neoplasms(3) Lymphoma(3) Neoplasm Metastasis(3) Carcinoma(3) Prostatic Neoplasms(3) Leukemia, Myeloid, Acute(3) (skip...) Phase 2:Ongoing: Leukemia(14) Leukemia, Myeloid(12) Leukemia, Myelogenous, Chronic, BCR-ABL Positive(7) Prostatic Neoplasms(6) Osteoarthritis(6) Syndrome(6) Leukemia, Myeloid, Acute(6) Carcinoma, Non-Small-Cell Lung(6) Breast Neoplasms(6) Osteoarthritis, Knee(5) Myelodysplastic Syndromes(5) (skip...) Phase 2:Finished: Influenza, Human(42) Asthma(33) Breast Neoplasms(28) Leukemia(28) Syndrome(24) Hypertension(23) Meningococcal Infections(22) Carcinoma(20) Pulmonary Disease, Chronic Obstructive(18) Neoplasms(18) Leukemia, Myeloid(17) (skip...) Phase 2:Aborted: Asthma(11) Breast Neoplasms(11) Carcinoma(10) Carcinoma, Non-Small-Cell Lung(9) Lung Neoplasms(8) Neoplasms(8) Leukemia(8) Syndrome(7) Hypertension(6) (5) Diabetes Mellitus(5) (skip...) Phase 3:Ongoing: Sclerosis(9) Urticaria(8) Syndrome(8) Multiple Sclerosis(8) Chronic Urticaria(7) Hypercholesterolemia(6) Breast Neoplasms(6) Leukemia(6) Prostatic Neoplasms(5) Cardiovascular Diseases(5) Leukemia, Myelogenous, Chronic, BCR-ABL Positive(5) (skip...) Phase 3:Finished: Hypertension(105) Diabetes Mellitus, Type 2(65) Diabetes Mellitus(62) Pulmonary Disease, Chronic Obstructive(55) Lung Diseases, Obstructive(55) Influenza, Human(50) Lung Diseases(45) Meningococcal Infections(35) Breast Neoplasms(34) Psoriasis(31) Meningitis(28) (skip...) Phase 3:Aborted: Carcinoma, Non-Small-Cell Lung(7) Leukemia(7) Uveitis(6) Breast Neoplasms(6) Syndrome(6) Pulmonary Disease, Chronic Obstructive(5) Macular Edema(5) Sclerosis(5) Multiple Sclerosis(5) Lung Neoplasms(5) Hepatitis(5) (skip...) Phase 4:Ongoing: Sclerosis(6) Multiple Sclerosis(5) Breast Neoplasms(2) Anemia, Sickle Cell(2) Multiple Sclerosis, Relapsing-Remitting(2) Carcinoma, Non-Small-Cell Lung(2) Polycythemia(2) Polycythemia Vera(2) Leukemia, Myeloid(2) Prostatic Neoplasms(1) Non-Radiographic Axial Spondyloarthritis(1) (skip...) Phase 4:Finished: Hypertension(63) Diabetes Mellitus(27) Diabetes Mellitus, Type 2(25) Sclerosis(20) Multiple Sclerosis(19) Pulmonary Disease, Chronic Obstructive(18) Lung Diseases, Obstructive(16) Macular Degeneration(16) Neoplasm Metastasis(16) Alzheimer Disease(14) Prostatic Neoplasms(13) (skip...) Phase 4:Aborted: Sclerosis(6) Multiple Sclerosis(6) Fibrosis(4) Hepatitis(4) Diabetes Mellitus(4) Hypertension(4) Breast Neoplasms(4) Multiple Sclerosis, Relapsing-Remitting(3) Asthma(3) Cystic Fibrosis(3) Infections(3) (skip...) Phase Not Applicable:Finished: Refractive Errors(4) Presbyopia(2) Heart Failure(2) Psoriasis(1) Arthritis, Psoriatic(1) Arthritis(1) Cardiovascular Diseases(1) Hyperopia(1) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases, Obstructive(1) Lung Diseases(1) (skip...) Phase Not Applicable:Aborted: Astigmatism(1) Cataract(1) |
ALL | 47 | 98 | 110 | 28 | 73 | 5 | 45 | 56 |
| 2023 | 5 ⬤ | 13 ⬤ | 23 ⬤ | 2 ⬤ | - | - | 1 ⬤ | 2 | |||
| 2022 | 13 ⬤ | 22 ⬤ | 20 ⬤ | 4 ⬤ | 1 | 1 | - | 1 | |||
| 2021 | 6 ⬤ | 19 ⬤ | 29 ⬤ | 6 ⬤ | 2 | - | - | - | |||
|
ABBV
(AbbVie Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(12) Carcinoma, Non-Small-Cell Lung(5) Lymphoma, B-Cell(4) Lymphoma(4) Lymphoma, Non-Hodgkin(4) Neoplasms, Plasma Cell(3) Multiple Myeloma(3) Lung Neoplasms(3) Leukemia, Lymphocytic, Chronic, B-Cell(3) Leukemia, Lymphoid(3) Hematologic Neoplasms(3) (skip...) Phase 1:Finished: Neoplasms(26) Leukemia(9) Lymphoma(7) Leukemia, Myeloid, Acute(5) Lymphoma, Non-Hodgkin(5) Leukemia, Lymphocytic, Chronic, B-Cell(5) Lung Neoplasms(5) Ovarian Neoplasms(5) Parkinson Disease(4) Leukemia, Myeloid(4) Leukemia, Lymphoid(4) (skip...) Phase 1:Aborted: Leukemia, Myeloid, Acute(5) Leukemia, Myeloid(5) Neoplasms, Plasma Cell(4) Multiple Myeloma(4) Leukemia(4) Lymphoma(4) Lymphoma, Non-Hodgkin(4) Colorectal Neoplasms(3) Carcinoma, Non-Small-Cell Lung(2) Lymphoma, B-Cell(2) Breast Neoplasms(2) (skip...) Phase 2:Ongoing: Lymphoma(5) Wet Macular Degeneration(3) Macular Degeneration(3) Leukemia, Lymphocytic, Chronic, B-Cell(3) Leukemia, Lymphoid(3) Leukemia(3) Carcinoma, Hepatocellular(2) Carcinoma(2) Alzheimer Disease(2) Choroidal Effusions(2) Carcinoma, Non-Small-Cell Lung(2) (skip...) Phase 2:Finished: Hepatitis C(21) Hepatitis C, Chronic(19) Hepatitis A(18) Hepatitis(17) Arthritis(15) Arthritis, Rheumatoid(12) Hepatitis, Chronic(10) Infections(10) Leukemia(8) Lung Neoplasms(8) Communicable Diseases(7) (skip...) Phase 2:Aborted: Arthritis(3) Alzheimer Disease(3) Arthritis, Rheumatoid(2) Neoplasms, Plasma Cell(2) Multiple Myeloma(2) Supranuclear Palsy, Progressive(2) Lung Neoplasms(2) Disease(2) Syndrome(1) Sjogren\'s Syndrome(1) Crohn Disease(1) (skip...) Phase 3:Ongoing: Migraine Disorders(8) Arthritis(8) Crohn Disease(5) Arthritis, Psoriatic(5) Leukemia, Myeloid, Acute(5) Leukemia, Myeloid(5) Leukemia(5) (5) Colitis, Ulcerative(5) Colitis(5) Eczema(4) (skip...) Phase 3:Finished: Hepatitis C(52) Hepatitis A(52) Hepatitis(47) Hepatitis C, Chronic(45) Infections(30) Psoriasis(25) Hepatitis, Chronic(22) Communicable Diseases(18) Parkinson Disease(12) Arthritis(11) Virus Diseases(10) (skip...) Phase 3:Aborted: Small Cell Lung Carcinoma(2) Lung Neoplasms(2) Hepatitis C, Chronic(2) Hepatitis C(2) Hepatitis A(2) Kidney Diseases(2) Eczema(1) Dermatitis(1) Dermatitis, Atopic(1) Schizophrenia(1) Glioblastoma(1) (skip...) Phase 4:Ongoing: Psoriasis(1) Glaucoma, Open-Angle(1) Glaucoma(1) Eczema(1) Dermatitis(1) Dermatitis, Atopic(1) Panuveitis(1) Uveitis(1) Leukemia, Myeloid, Acute(1) Leukemia, Myeloid(1) Leukemia(1) (skip...) Phase 4:Finished: Arthritis(5) Arthritis, Rheumatoid(4) Fibrosis(2) Exocrine Pancreatic Insufficiency(2) Cystic Fibrosis(2) Hypogonadism(2) Psoriasis(2) HIV Infections(2) Facies(1) Migraine Disorders(1) Pancreatitis, Chronic(1) (skip...) Phase 4:Aborted: Exocrine Pancreatic Insufficiency(2) Pancreatitis, Chronic(1) Pancreatitis(1) Cystic Fibrosis(1) Pancreatic Neoplasms(1) Spondylarthritis(1) |
ALL | 38 | 36 | 83 | 6 | 42 | 6 | 48 | 41 |
| 2023 | 13 ⬤ | 9 ⬤ | 22 ⬤ | 2 ⬤ | - | - | - | - | |||
| 2022 | 7 ⬤ | 6 ⬤ | 13 ⬤ | 2 ⬤ | - | - | 1 | - | |||
| 2021 | 3 ⬤ | 6 ⬤ | 9 ⬤ | 1 | 1 | - | 1 | 1 | |||
|
LLY
(Lilly Eli & Company) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Diabetes Mellitus(7) Neoplasms(6) Diabetes Mellitus, Type 2(5) Breast Neoplasms(5) Overweight(4) Carcinoma, Non-Small-Cell Lung(4) Renal Insufficiency(3) Obesity(3) Liver Failure(3) Hepatic Insufficiency(3) Dermatitis(2) (skip...) Phase 1:Finished: Diabetes Mellitus(62) Diabetes Mellitus, Type 2(55) Neoplasms(48) Diabetes Mellitus, Type 1(24) Neoplasm Metastasis(24) Depressive Disorder, Major(17) Depressive Disorder(17) Alzheimer Disease(12) Carcinoma, Non-Small-Cell Lung(10) Psoriasis(8) Overweight(7) (skip...) Phase 1:Aborted: Diabetes Mellitus(5) Neoplasms(5) Diabetes Mellitus, Type 1(3) Diabetes Mellitus, Type 2(3) Triple Negative Breast Neoplasms(2) Carcinoma, Non-Small-Cell Lung(2) Carcinoma, Renal Cell(2) Neoplasm Metastasis(2) Carcinoma(2) Leukemia(2) Psoriasis(1) (skip...) Phase 2:Ongoing: Obesity(6) Overweight(5) Diabetes Mellitus, Type 2(3) Diabetes Mellitus(3) Breast Neoplasms(3) Neuralgia(2) Renal Insufficiency, Chronic(2) Kidney Diseases(2) Arthritis, Rheumatoid(2) Arthritis(2) Alzheimer Disease(2) (skip...) Phase 2:Finished: Carcinoma, Non-Small-Cell Lung(65) Lung Neoplasms(62) Breast Neoplasms(36) Diabetes Mellitus(23) Neoplasms(20) Diabetes Mellitus, Type 2(19) Carcinoma(19) Colorectal Neoplasms(15) Ovarian Neoplasms(10) Arthritis, Rheumatoid(9) Arthritis(9) (skip...) Phase 2:Aborted: Lung Neoplasms(13) Carcinoma, Non-Small-Cell Lung(8) Diabetes Mellitus, Type 2(5) Diabetes Mellitus(5) Small Cell Lung Carcinoma(4) Carcinoma(3) Arthritis, Rheumatoid(2) Arthritis(2) Alzheimer Disease(2) Headache(2) Migraine Disorders(2) (skip...) Phase 3:Ongoing: Diabetes Mellitus(16) Diabetes Mellitus, Type 2(15) Obesity(15) Overweight(10) (8) Breast Neoplasms(8) Eczema(6) Dermatitis(6) Dermatitis, Atopic(6) Colitis, Ulcerative(6) Colitis(6) (skip...) Phase 3:Finished: Diabetes Mellitus(79) Diabetes Mellitus, Type 2(58) Depressive Disorder(24) Attention Deficit Disorder with Hyperactivity(23) Hyperkinesis(22) Depressive Disorder, Major(21) Diabetes Mellitus, Type 1(20) Lung Neoplasms(19) Osteoporosis(18) Carcinoma, Non-Small-Cell Lung(18) Depression(17) (skip...) Phase 3:Aborted: Lupus Erythematosus, Systemic(4) Arthritis, Rheumatoid(4) Arthritis(4) Alzheimer Disease(3) Hypercholesterolemia(2) Schizophrenia(2) (1) Colitis, Ulcerative(1) Colitis(1) Psoriasis(1) Eczema(1) (skip...) Phase 4:Ongoing: Diabetes Mellitus, Type 2(4) Diabetes Mellitus(4) Arthritis(3) Arthritis, Rheumatoid(2) Psoriasis(1) Arthritis, Psoriatic(1) Phase 4:Finished: Diabetes Mellitus, Type 2(23) Depressive Disorder(21) Attention Deficit Disorder with Hyperactivity(19) Diabetes Mellitus(19) Schizophrenia(16) Depression(16) Osteoporosis(16) Hyperkinesis(14) Depressive Disorder, Major(13) Erectile Dysfunction(12) Disease(11) (skip...) Phase 4:Aborted: Breast Neoplasms(2) Diabetes Mellitus, Type 2(2) Diabetes Mellitus(2) Attention Deficit Disorder with Hyperactivity(2) Hyperkinesis(2) Myofascial Pain Syndromes(1) Fibromyalgia(1) Bipolar Disorder(1) Marijuana Abuse(1) Disease(1) Phase Not Applicable:Ongoing: Diabetes Mellitus, Type 2(1) Diabetes Mellitus(1) Phase Not Applicable:Finished: Diabetes Mellitus(5) Diabetes Mellitus, Type 1(4) Diabetes Mellitus, Type 2(1) Migraine Disorders(1) |
ALL | 65 | 32 | 76 | 7 | 37 | 4 | 17 | 48 |
| 2023 | 33 ⬤ | 10 ⬤ | 22 ⬤ | 2 ⬤ | 1 ⬤ | - | - | 1 ⬤ | |||
| 2022 | 15 ⬤ | 8 ⬤ | 17 ⬤ | 3 ⬤ | 1 | - | - | - | |||
| 2021 | 5 ⬤ | 3 ⬤ | 7 ⬤ | - | - | 1 | - | - | |||
|
PFE
(Pfizer Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Multiple Myeloma(6) Neoplasms, Plasma Cell(5) Neoplasms(5) Carcinoma, Non-Small-Cell Lung(4) Breast Neoplasms(4) Liver Diseases(3) Squamous Cell Carcinoma of Head and Neck(3) Carcinoma, Squamous Cell(3) Melanoma(3) Lung Neoplasms(3) Lymphoma(3) (skip...) Phase 1:Finished: Diabetes Mellitus, Type 2(38) Alzheimer Disease(38) Neoplasms(32) Diabetes Mellitus(27) Arthritis, Rheumatoid(18) Arthritis(18) Renal Insufficiency(17) Liver Diseases(16) Overweight(14) Schizophrenia(11) Urinary Bladder, Overactive(9) (skip...) Phase 1:Aborted: Neoplasms(21) Breast Neoplasms(10) Carcinoma, Non-Small-Cell Lung(4) Lung Neoplasms(4) Diabetes Mellitus, Type 2(4) Schizophrenia(4) Carcinoma, Renal Cell(3) Carcinoma(3) Hypertension(3) Hypercholesterolemia(3) Colorectal Neoplasms(3) (skip...) Phase 2:Ongoing: Breast Neoplasms(8) Neoplasms, Plasma Cell(4) Multiple Myeloma(4) COVID-19(3) Carcinoma, Non-Small-Cell Lung(3) Lymphoma, Large B-Cell, Diffuse(2) Lymphoma, B-Cell(2) Lymphoma(2) (2) Colitis, Ulcerative(2) Colitis(2) (skip...) Phase 2:Finished: Arthritis(25) Carcinoma, Non-Small-Cell Lung(25) Arthritis, Rheumatoid(24) Breast Neoplasms(20) Lung Neoplasms(18) Alzheimer Disease(16) Psoriasis(14) Carcinoma(14) Diabetes Mellitus, Type 2(13) Diabetes Mellitus(13) Carcinoma, Renal Cell(13) (skip...) Phase 2:Aborted: Breast Neoplasms(15) Carcinoma, Non-Small-Cell Lung(9) Lung Neoplasms(9) Diabetes Mellitus(7) Neoplasms(7) Infections(6) Alzheimer Disease(6) Diabetes Mellitus, Type 2(6) Schizophrenia(5) Osteoarthritis(5) Neuralgia(5) (skip...) Phase 3:Ongoing: Migraine Disorders(10) Anemia, Sickle Cell(9) Hemophilia A(7) Hemophilia B(6) Neoplasms, Plasma Cell(4) Multiple Myeloma(4) Breast Neoplasms(4) (3) Pneumococcal Infections(3) Eczema(3) Dermatitis(3) (skip...) Phase 3:Finished: Depression(31) Infections(30) Depressive Disorder(29) Arthritis(28) Pneumococcal Infections(27) Communicable Diseases(26) Depressive Disorder, Major(25) Arthritis, Rheumatoid(19) Disease(17) (16) Pneumonia(14) (skip...) Phase 3:Aborted: Osteoarthritis(9) Infections(9) Alzheimer Disease(8) Hypertension(7) Diabetes Mellitus(7) Communicable Diseases(7) Hypertension, Pulmonary(5) Anxiety Disorders(5) Carcinoma(5) Carcinoma, Non-Small-Cell Lung(5) Hyperlipidemias(5) (skip...) Phase 4:Ongoing: Migraine Disorders(4) Carcinoma, Non-Small-Cell Lung(2) Neoplasms, Plasma Cell(1) Multiple Myeloma(1) Leukemia, Lymphoid(1) Precursor Cell Lymphoblastic Leukemia-Lymphoma(1) Leukemia(1) Invasive Fungal Infections(1) Mycoses(1) Myocarditis(1) Anemia, Sickle Cell(1) (skip...) Phase 4:Finished: Arthritis(18) Arthritis, Rheumatoid(14) Infections(12) Communicable Diseases(10) Psoriasis(9) Hemophilia A(9) Renal Insufficiency(9) Spondylitis, Ankylosing(8) Spondylitis(8) Depressive Disorder(8) Depression(8) (skip...) Phase 4:Aborted: Arthritis(4) Hemophilia A(4) Attention Deficit Disorder with Hyperactivity(3) Hyperkinesis(3) Arthritis, Rheumatoid(3) Wounds and Injuries(3) Brain Injuries(3) (2) Endocrine System Diseases(2) Dwarfism, Pituitary(2) Venous Thromboembolism(2) (skip...) Phase Not Applicable:Finished: Meningitis(11) Meningococcal Infections(11) Meningitis, Cryptococcal(10) Infections(8) HIV Infections(7) Communicable Diseases(6) Acquired Immunodeficiency Syndrome(6) Mycobacterium avium-intracellulare Infection(4) Mycobacterium Infections(4) Candidiasis(4) Immunologic Deficiency Syndromes(3) (skip...) Phase Not Applicable:Aborted: Disease Progression(1) Amyloidosis(1) Cardiomyopathies(1) Heart Failure(1) Alzheimer Disease(1) Diabetes Mellitus, Type 2(1) Diabetes Mellitus(1) Cystitis, Interstitial(1) Cystitis(1) |
ALL | 57 | 51 | 74 | 13 | 73 | 7 | 52 | 63 |
| 2023 | 26 ⬤ | 10 ⬤ | 13 ⬤ | 2 ⬤ | 6 ⬤ | - | - | - | |||
| 2022 | 14 ⬤ | 13 ⬤ | 22 ⬤ | 8 ⬤ | 1 | - | - | - | |||
| 2021 | 4 ⬤ | 9 ⬤ | 11 ⬤ | 2 ⬤ | - | - | - | - | |||
|
BMY
(Bristol-Myers Squibb Company) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(4) Neoplasms, Plasma Cell(2) Multiple Myeloma(2) Lymphoma, Non-Hodgkin(2) Lymphoma(2) Prostatic Neoplasms(1) Heart Failure(1) Lupus Erythematosus, Systemic(1) Liver Diseases(1) Liver Failure(1) Hepatic Insufficiency(1) (skip...) Phase 1:Finished: Hepatitis C(20) Neoplasms(19) HIV Infections(17) Arthritis(16) Thrombosis(15) Arthritis, Rheumatoid(14) Alzheimer Disease(11) Melanoma(10) Psoriasis(9) Heart Failure(7) Carcinoma(7) (skip...) Phase 1:Abnormal: Glioblastoma(1) Phase 1:Aborted: Leukemia(5) Melanoma(3) Leukemia, Lymphocytic, Chronic, B-Cell(3) Leukemia, Lymphoid(3) Lymphoma(3) Leukemia, Myelogenous, Chronic, BCR-ABL Positive(3) Leukemia, Myeloid(3) Neoplasms(3) Liver Diseases(2) Hypercholesterolemia(2) Hepatitis C(2) (skip...) Phase 2:Ongoing: Neoplasms(9) Carcinoma(5) Carcinoma, Non-Small-Cell Lung(4) Lung Neoplasms(4) Lupus Erythematosus, Systemic(3) Cardiomyopathies(3) Melanoma(3) Prostatic Neoplasms(3) Colorectal Neoplasms(3) Carcinoma, Hepatocellular(3) Multiple Myeloma(3) (skip...) Phase 2:Finished: Hepatitis(30) Hepatitis C(24) Hepatitis A(18) Melanoma(16) Leukemia(15) Carcinoma, Non-Small-Cell Lung(13) Breast Neoplasms(13) Arthritis(12) Leukemia, Myelogenous, Chronic, BCR-ABL Positive(12) Leukemia, Myeloid(12) Arthritis, Rheumatoid(11) (skip...) Phase 2:Abnormal: Ketosis(1) Sclerosis(1) Multiple Sclerosis, Chronic Progressive(1) Multiple Sclerosis(1) Central Nervous System Neoplasms(1) Nervous System Neoplasms(1) Glioblastoma(1) Phase 2:Aborted: Carcinoma, Non-Small-Cell Lung(8) Lung Neoplasms(8) Hepatitis(6) Hepatitis C(6) Hepatitis A(5) Melanoma(5) Hepatitis C, Chronic(4) Leukemia(4) Carcinoma(3) Neoplasms(3) Breast Neoplasms(3) (skip...) Phase 3:Ongoing: Carcinoma(8) Melanoma(7) Carcinoma, Non-Small-Cell Lung(6) Lung Neoplasms(5) Carcinoma, Renal Cell(5) Syndrome(4) Hypertrophy(4) Cardiomyopathy, Hypertrophic(4) Cardiomyopathies(4) Neoplasms, Plasma Cell(3) Multiple Myeloma(3) (skip...) Phase 3:Finished: Hepatitis(35) Hepatitis C(24) Arthritis(24) Hepatitis A(24) Arthritis, Rheumatoid(22) HIV Infections(17) Melanoma(13) Hepatitis B(12) Lung Neoplasms(11) Hepatitis B, Chronic(10) Carcinoma, Non-Small-Cell Lung(8) (skip...) Phase 3:Aborted: Hepatitis C(3) Hepatitis(3) Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Hepatitis A(2) Leukemia, Myelogenous, Chronic, BCR-ABL Positive(2) Leukemia(2) Squamous Cell Carcinoma of Head and Neck(1) Carcinoma, Squamous Cell(1) Arteritis(1) Giant Cell Arteritis(1) (skip...) Phase 4:Ongoing: Psoriasis(3) Hypertrophy(1) Cardiomyopathy, Hypertrophic(1) Cardiomyopathies(1) beta-Thalassemia(1) Thalassemia(1) Myelodysplastic Syndromes(1) Anemia(1) Preleukemia(1) (1) Colitis, Ulcerative(1) (skip...) Phase 4:Finished: HIV Infections(4) Atrial Fibrillation(3) Hepatitis(3) Hepatitis B, Chronic(3) Hepatitis B(3) Syndrome(3) Diabetes Mellitus, Type 2(3) Lung Neoplasms(2) Carcinoma, Renal Cell(2) Arthritis, Rheumatoid(2) Arthritis(2) (skip...) Phase 4:Aborted: Hepatitis(1) Hepatitis B, Chronic(1) Hepatitis B(1) Schizophrenia(1) Syndrome(1) Metabolic Syndrome(1) HIV Infections(1) Phase Not Applicable:Ongoing: Parkinson Disease(2) Critical Illness(1) Sclerosis(1) Tuberous Sclerosis(1) Atrial Flutter(1) Atrial Fibrillation(1) Parkinsonian Disorders(1) Lower Urinary Tract Symptoms(1) Urinary Bladder, Underactive(1) Hypokinesia(1) Phase Not Applicable:Finished: HIV Infections(11) Infections(8) Acquired Immunodeficiency Syndrome(8) Communicable Diseases(5) Obesity(4) Candidiasis(3) Lung Neoplasms(2) Pediatric Obesity(2) Diabetes Mellitus(2) Candidiasis, Oral(2) AIDS-Related Complex(2) (skip...) Phase Not Applicable:Abnormal: Depressive Disorder, Treatment-Resistant(1) Depressive Disorder(1) Depression(1) Phase Not Applicable:Aborted: Pain, Postoperative(1) Surgical Wound(1) Surgical Wound Infection(1) Wound Infection(1) Choledocholithiasis(1) |
ALL | 36 | 62 | 60 | 8 | 36 | 1 | 18 | 36 |
| 2023 | 20 ⬤ | 7 ⬤ | 8 ⬤ | 4 ⬤ | 1 ⬤ | - | - | - | |||
| 2022 | 6 ⬤ | 13 ⬤ | 11 ⬤ | 2 ⬤ | 3 | - | - | 1 | |||
| 2021 | 5 ⬤ | 9 ⬤ | 8 ⬤ | - | - | - | - | - | |||
|
SNY
(Sanofi SA) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(4) Neoplasms, Plasma Cell(2) Multiple Myeloma(2) Hemophilia A(1) Arthritis, Rheumatoid(1) Arthritis(1) Influenza, Human(1) Leukemia, Myeloid, Acute(1) Leukemia, Myeloid(1) Leukemia(1) Osteogenesis Imperfecta(1) (skip...) Phase 1:Finished: Neoplasms(36) Diabetes Mellitus(27) Diabetes Mellitus, Type 1(19) Diabetes Mellitus, Type 2(17) Hypercholesterolemia(9) Leukemia(9) Multiple Sclerosis(8) Influenza, Human(7) Arthritis, Rheumatoid(6) Arthritis(6) Lymphoma(6) (skip...) Phase 1:Aborted: Smallpox(2) Neoplasms(2) Coronavirus Infections(1) Herpes Genitalis(1) Herpes Simplex(1) Neoplasms, Plasma Cell(1) Multiple Myeloma(1) Sclerosis(1) Amyotrophic Lateral Sclerosis(1) Motor Neuron Disease(1) Diabetes Mellitus, Type 1(1) (skip...) Phase 2:Ongoing: Dermatitis(5) Dermatitis, Atopic(5) Influenza, Human(4) Asthma(4) (4) Neoplasms, Plasma Cell(4) Multiple Myeloma(4) Lung Neoplasms(4) Sclerosis(4) Hidradenitis(3) Hidradenitis Suppurativa(3) (skip...) Phase 2:Finished: Influenza, Human(36) Breast Neoplasms(19) (18) Severe Dengue(17) Hemorrhagic Fevers, Viral(17) Dengue(17) Meningococcal Infections(17) Meningitis(16) Orthomyxoviridae Infections(15) Lung Neoplasms(15) Carcinoma, Non-Small-Cell Lung(14) (skip...) Phase 2:Abnormal: Melanoma(2) Phase 2:Aborted: Leukemia(6) Lymphoma(6) Breast Neoplasms(5) Syndrome(5) Malaria(4) Leukemia, Myeloid, Acute(4) Carcinoma, Non-Small-Cell Lung(4) Lymphoma, Non-Hodgkin(4) Sclerosis(4) Leukemia, Lymphoid(3) Precursor Cell Lymphoblastic Leukemia-Lymphoma(3) (skip...) Phase 3:Ongoing: Sclerosis(8) Multiple Sclerosis(8) Hemophilia A(4) Neoplasms, Plasma Cell(4) Multiple Myeloma(4) Pulmonary Disease, Chronic Obstructive(3) Lung Diseases, Obstructive(3) Lung Diseases(3) Multiple Sclerosis, Chronic Progressive(3) Influenza, Human(2) Fabry Disease(2) (skip...) Phase 3:Finished: Diabetes Mellitus(77) Diabetes Mellitus, Type 2(67) Diphtheria(45) Whooping Cough(42) Tetanus(39) Influenza, Human(28) Hepatitis B(24) Meningococcal Infections(23) Poliomyelitis(22) Hepatitis(19) Depressive Disorder(19) (skip...) Phase 3:Abnormal: Influenza, Human(1) Colorectal Neoplasms(1) Phase 3:Aborted: Diabetes Mellitus, Type 2(14) Diabetes Mellitus(10) Hypercholesterolemia(4) Dyslipidemias(3) Recurrence(3) Atrial Fibrillation(3) Breast Neoplasms(2) Giant Cell Arteritis(2) Polymyalgia Rheumatica(2) Polycystic Kidney, Autosomal Dominant(2) Polycystic Kidney Diseases(2) (skip...) Phase 4:Ongoing: Dermatitis(3) Dermatitis, Atopic(3) Asthma(3) Eczema(2) Glycogen Storage Disease Type II(2) Fabry Disease(2) Eosinophilic Esophagitis(1) Esophagitis(1) Meningococcal Infections(1) Rhinitis, Allergic(1) Rhinitis(1) (skip...) Phase 4:Finished: Diabetes Mellitus, Type 2(65) Diabetes Mellitus(58) Influenza, Human(33) Diphtheria(20) Hypertension(18) Whooping Cough(17) Tetanus(16) Diabetes Mellitus, Type 1(12) Rhinitis, Allergic(10) Rhinitis(10) Tetany(10) (skip...) Phase 4:Aborted: Diabetes Mellitus, Type 2(7) Diabetes Mellitus(7) Atrial Fibrillation(3) Glycogen Storage Disease Type II(3) Pneumonia(3) Glycogen Storage Disease(2) Osteoporosis(2) Fabry Disease(2) Bronchitis, Chronic(2) Bronchitis(2) Infections(2) (skip...) Phase Not Applicable:Ongoing: Rare Diseases(1) Gaucher Disease(1) Diabetes Mellitus, Type 2(1) Diabetes Mellitus(1) Phase Not Applicable:Finished: Lipidoses(1) Niemann-Pick Disease, Type C(1) Niemann-Pick Diseases(1) Niemann-Pick Disease, Type A(1) Hepatitis(1) Hepatitis B(1) Diabetes Mellitus(1) Osteoarthritis, Hip(1) Osteoarthritis(1) Alopecia Areata(1) Alopecia(1) (skip...) Phase Not Applicable:Aborted: Tissue Adhesions(2) Sinusitis(1) |
ALL | 20 | 78 | 52 | 15 | 47 | 2 | 30 | 48 |
| 2023 | 6 ⬤ | 21 ⬤ | 7 ⬤ | 5 ⬤ | - | - | - | - | |||
| 2022 | 4 ⬤ | 17 ⬤ | 10 ⬤ | 2 ⬤ | - | - | - | - | |||
| 2021 | 3 ⬤ | 18 ⬤ | 6 ⬤ | 3 ⬤ | 1 | - | - | - | |||
|
NVO
(Novo Nordisk A S) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Liver Diseases(3) Obesity(3) Diabetes Mellitus, Type 2(3) Overweight(2) Diabetes Mellitus(2) Neoplasms(1) Dyslipidemias(1) Alcoholism(1) Non-alcoholic Fatty Liver Disease(1) Fatty Liver(1) Inflammation(1) (skip...) Phase 1:Finished: Diabetes Mellitus(147) Diabetes Mellitus, Type 2(105) Diabetes Mellitus, Type 1(68) Blood Coagulation Disorders(31) Hemostatic Disorders(31) Overweight(28) Hemophilia A(25) Obesity(19) Nutrition Disorders(19) Hemophilia B(14) Inflammation(7) (skip...) Phase 1:Aborted: Overweight(4) Inflammation(3) Nutrition Disorders(3) Blood Coagulation Disorders(2) Hemophilia A(2) Hemostatic Disorders(2) Obesity(2) Lupus Erythematosus, Systemic(2) Renal Insufficiency, Chronic(1) Kidney Diseases(1) Prostatic Neoplasms(1) (skip...) Phase 2:Ongoing: Diabetes Mellitus, Type 2(2) Overweight(2) Diabetes Mellitus(2) Hyperoxaluria, Primary(2) Obesity(1) Renal Insufficiency, Chronic(1) Kidney Diseases(1) Amyloidosis(1) Cardiomyopathies(1) Anemia, Sickle Cell(1) Non-alcoholic Fatty Liver Disease(1) (skip...) Phase 2:Finished: Diabetes Mellitus(32) Diabetes Mellitus, Type 2(28) Blood Coagulation Disorders(19) Hemostatic Disorders(19) Hemorrhage(9) Hemophilia A(7) Inflammation(6) Diabetes Mellitus, Type 1(6) Hemophilia B(5) Obesity(4) Cerebral Hemorrhage(4) (skip...) Phase 2:Aborted: Inflammation(4) Arthritis, Rheumatoid(3) Arthritis(3) Hemorrhage(2) Blood Coagulation Disorders(2) Hemostatic Disorders(2) (1) Colitis, Ulcerative(1) Colitis(1) Diabetes Mellitus, Type 1(1) Diabetes Mellitus(1) (skip...) Phase 3:Ongoing: Diabetes Mellitus, Type 2(16) Diabetes Mellitus(16) Obesity(13) Hemophilia A(9) Overweight(6) Kidney Diseases(4) Hemophilia B(4) Alzheimer Disease(3) Renal Insufficiency, Chronic(3) Syndrome(2) Gonadal Dysgenesis(2) (skip...) Phase 3:Finished: Diabetes Mellitus(184) Diabetes Mellitus, Type 2(143) Diabetes Mellitus, Type 1(49) Blood Coagulation Disorders(21) Hemostatic Disorders(21) Obesity(19) Hemophilia A(16) Overweight(16) Dwarfism, Pituitary(11) Nutrition Disorders(10) Hemorrhage(10) (skip...) Phase 3:Aborted: Diabetes Mellitus(14) Diabetes Mellitus, Type 2(13) Diabetes Mellitus, Type 1(3) Hemorrhage(2) Blood Coagulation Disorders(2) Hemostatic Disorders(2) Hemophilia A(1) Urinary Tract Infections(1) Communicable Diseases(1) Infections(1) Asthma(1) (skip...) Phase 4:Ongoing: Diabetes Mellitus, Type 2(2) Diabetes Mellitus(2) Obesity(1) Phase 4:Finished: Diabetes Mellitus(75) Diabetes Mellitus, Type 2(69) Diabetes Mellitus, Type 1(11) Blood Coagulation Disorders(4) Hemophilia A(4) Hemostatic Disorders(4) Genetic Diseases, Inborn(3) Turner Syndrome(3) Hemophilia B(3) Fetal Growth Retardation(2) Syndrome(2) (skip...) Phase 4:Aborted: Diabetes Mellitus(4) Diabetes Mellitus, Type 2(3) Endocrine System Diseases(1) Dwarfism, Pituitary(1) Diabetes Mellitus, Type 1(1) Phase Not Applicable:Finished: Diabetes Mellitus, Type 1(1) Diabetes Mellitus(1) |
ALL | 21 | 10 | 49 | 3 | 8 | - | 6 | 15 |
| 2023 | 14 ⬤ | 1 ⬤ | 15 ⬤ | - | 1 ⬤ | - | - | - | |||
| 2022 | 6 ⬤ | 3 ⬤ | 13 ⬤ | 2 | - | - | - | - | |||
| 2021 | - | 3 ⬤ | 11 ⬤ | 1 | - | - | - | 1 | |||
|
TAK
(Takeda Pharmaceutical Company Limited) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(3) Liver Diseases(2) Neoplasms, Plasma Cell(2) Multiple Myeloma(2) Carcinoma, Non-Small-Cell Lung(2) Renal Insufficiency(1) Glomerulonephritis(1) Kidney Diseases(1) Triple Negative Breast Neoplasms(1) Squamous Cell Carcinoma of Head and Neck(1) Breast Neoplasms(1) (skip...) Phase 1:Finished: Gastroesophageal Reflux(6) Liver Diseases(5) Diabetes Mellitus(4) Esophagitis, Peptic(4) Diabetes Mellitus, Type 2(3) Neoplasms(3) Narcolepsy(2) Epilepsy(2) Renal Insufficiency(2) Esophagitis(2) Schizophrenia(2) (skip...) Phase 1:Aborted: Neoplasms, Plasma Cell(2) Multiple Myeloma(2) Cognitive Dysfunction(2) Schizophrenia(2) Coronavirus Infections(1) Alzheimer Disease(1) Gastroesophageal Reflux(1) Lupus Nephritis(1) Nephritis(1) Attention Deficit Disorder with Hyperactivity(1) Hyperkinesis(1) (skip...) Phase 2:Ongoing: Multiple Myeloma(4) Leukemia(4) Neoplasms(3) Neoplasms, Plasma Cell(3) Leukemia, Myeloid(3) Narcolepsy(2) Lymphoma(2) Carcinoma, Squamous Cell(2) Neoplasms, Squamous Cell(2) Neoplasm Metastasis(2) Celiac Disease(2) (skip...) Phase 2:Finished: Diabetes Mellitus(11) Diabetes Mellitus, Type 2(7) Dengue(6) Hypertension(5) Renal Insufficiency(5) (5) Arthritis(4) Sleep Initiation and Maintenance Disorders(4) Lymphoma(3) Carcinoma(3) Gastroesophageal Reflux(3) (skip...) Phase 2:Aborted: Narcolepsy(2) Crohn Disease(2) Recurrence(2) Arthritis, Rheumatoid(2) Arthritis(2) Diabetes Mellitus(2) Papillomavirus Infections(2) Infections(2) Syndrome(1) Myelodysplastic Syndromes(1) Preleukemia(1) (skip...) Phase 3:Ongoing: Crohn Disease(8) (6) Colitis, Ulcerative(6) Colitis(6) Syndrome(5) Immunologic Deficiency Syndromes(4) Primary Immunodeficiency Diseases(4) Dengue(3) Psoriasis(2) Alpha 1-Antitrypsin Deficiency(2) Liver Diseases(2) (skip...) Phase 3:Finished: Diabetes Mellitus(39) Diabetes Mellitus, Type 2(24) (23) Hypertension(21) Essential Hypertension(17) Esophagitis, Peptic(15) Gastroesophageal Reflux(15) Depressive Disorder, Major(13) Depression(13) Depressive Disorder(13) Disease(12) (skip...) Phase 3:Aborted: Diabetes Mellitus(15) Diabetes Mellitus, Type 2(12) Hypercholesterolemia(4) Bipolar Disorder(3) Cognitive Dysfunction(2) Alzheimer Disease(2) Hypertension(2) Heart Failure(2) Cholangitis, Sclerosing(1) Cholangitis(1) Inflammatory Bowel Diseases(1) (skip...) Phase 4:Ongoing: Crohn Disease(4) Mucopolysaccharidosis II(3) Syndrome(2) Mucopolysaccharidoses(2) (2) Colitis, Ulcerative(2) Colitis(2) Lymphoma(2) Lymphoma, T-Cell, Cutaneous(1) Lymphoma, T-Cell, Peripheral(1) Lymphoma, T-Cell(1) (skip...) Phase 4:Finished: Diabetes Mellitus(13) Diabetes Mellitus, Type 2(7) Gastroesophageal Reflux(6) Esophagitis, Peptic(5) Hypertension(4) Sleep Initiation and Maintenance Disorders(4) Crohn Disease(3) Depressive Disorder, Major(3) Depression(3) Depressive Disorder(3) Hyperlipidemias(2) (skip...) Phase 4:Aborted: (2) Colitis, Ulcerative(2) Colitis(2) Crohn Disease(2) Emphysema(1) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases, Obstructive(1) Lung Diseases(1) Alpha 1-Antitrypsin Deficiency(1) Neoplasms, Plasma Cell(1) Multiple Myeloma(1) (skip...) Phase Not Applicable:Ongoing: Hemophilia A(1) Phase Not Applicable:Finished: Celiac Disease(1) |
ALL | 14 | 32 | 45 | 12 | 23 | 1 | 13 | 8 |
| 2023 | 7 ⬤ | 6 ⬤ | 11 ⬤ | 2 ⬤ | 1 ⬤ | - | - | 1 ⬤ | |||
| 2022 | 1 ⬤ | 5 ⬤ | 9 ⬤ | 3 ⬤ | - | - | - | - | |||
| 2021 | 3 ⬤ | 5 ⬤ | 12 ⬤ | 3 ⬤ | 2 | - | - | - | |||
|
AMGN
(Amgen Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Lung Neoplasms(4) Neoplasms(3) Prostatic Neoplasms(3) Small Cell Lung Carcinoma(3) Leukemia(3) Carcinoma, Non-Small-Cell Lung(2) Eczema(1) Dermatitis(1) Dermatitis, Atopic(1) Renal Insufficiency(1) Obesity(1) (skip...) Phase 1:Finished: Neoplasms(18) Lupus Erythematosus, Systemic(10) Multiple Myeloma(8) Neoplasms, Plasma Cell(7) Lymphoma(7) Kidney Diseases(6) Bone Diseases, Metabolic(6) Vasculitis(5) Liver Diseases(5) Migraine Disorders(5) Renal Insufficiency(5) (skip...) Phase 1:Abnormal: Small Cell Lung Carcinoma(1) Lung Neoplasms(1) Phase 1:Aborted: Leukemia, Myeloid, Acute(5) Leukemia, Myeloid(5) Leukemia(5) Multiple Myeloma(4) Neoplasms, Plasma Cell(3) Diabetes Mellitus, Type 2(3) Diabetes Mellitus(3) Neoplasms(3) Carcinoma, Non-Small-Cell Lung(3) Migraine Disorders(2) Asthma(2) (skip...) Phase 2:Ongoing: Neoplasms(4) (2) Colitis, Ulcerative(2) Colitis(2) Carcinoma, Non-Small-Cell Lung(2) Leukemia, Lymphoid(2) Precursor Cell Lymphoblastic Leukemia-Lymphoma(2) Leukemia(2) Overweight(1) Diabetes Mellitus, Type 2(1) Obesity(1) (skip...) Phase 2:Finished: Colorectal Neoplasms(16) Lung Neoplasms(13) Anemia(13) Neoplasms(13) Arthritis(12) Carcinoma(11) Lymphoma(11) Multiple Myeloma(11) Breast Neoplasms(9) Neoplasm Metastasis(9) Carcinoma, Non-Small-Cell Lung(9) (skip...) Phase 2:Abnormal: Lung Neoplasms(1) Prostatic Neoplasms(1) Lymphoma, Non-Hodgkin(1) Lymphoma(1) Ureteral Neoplasms(1) Kidney Neoplasms(1) Carcinoma, Transitional Cell(1) Urinary Bladder Neoplasms(1) Phase 2:Aborted: Multiple Myeloma(4) Arthritis, Rheumatoid(4) Arthritis(4) Neoplasms, Plasma Cell(3) Adenocarcinoma(3) Anemia(3) Schizophrenia(2) Crohn Disease(2) Neoplasms(2) Anemia, Aplastic(1) Prostatic Neoplasms(1) (skip...) Phase 3:Ongoing: Eczema(7) Dermatitis(7) Dermatitis, Atopic(7) Psoriasis(5) Lung Neoplasms(4) Carcinoma, Non-Small-Cell Lung(3) Melanoma(2) Small Cell Lung Carcinoma(2) Esophageal Neoplasms(2) Stomach Neoplasms(2) Adenocarcinoma(2) (skip...) Phase 3:Finished: Kidney Diseases(26) Arthritis(22) Renal Insufficiency, Chronic(22) Psoriasis(22) Osteoporosis(20) Neoplasm Metastasis(18) Hyperparathyroidism(16) Arthritis, Rheumatoid(14) Hypercholesterolemia(13) Anemia(13) Hyperparathyroidism, Secondary(13) (skip...) Phase 3:Aborted: Renal Insufficiency, Chronic(5) Kidney Diseases(5) Anemia(4) Carcinoma, Non-Small-Cell Lung(3) Lung Neoplasms(3) Dyslipidemias(2) Osteogenesis Imperfecta(2) Stomach Neoplasms(2) Fallopian Tube Neoplasms(2) Carcinoma, Ovarian Epithelial(2) Ovarian Neoplasms(2) (skip...) Phase 4:Ongoing: Osteoporosis, Postmenopausal(1) Osteoporosis(1) Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis(1) Vasculitis(1) Infarction(1) Myocardial Infarction(1) Cardiovascular Diseases(1) Giant Cell Tumor of Bone(1) Bone Neoplasms(1) Giant Cell Tumors(1) Neoplasm, Residual(1) (skip...) Phase 4:Finished: Arthritis(14) Kidney Diseases(11) Arthritis, Rheumatoid(10) Psoriasis(9) Renal Insufficiency, Chronic(8) Hyperparathyroidism(6) Migraine Disorders(5) Hyperparathyroidism, Secondary(5) Renal Insufficiency(5) Kidney Failure, Chronic(5) Anemia(5) (skip...) Phase 4:Aborted: Arthritis, Rheumatoid(2) Arthritis(2) Migraine Disorders(1) Bone Diseases(1) Anemia(1) Psoriasis(1) Phase Not Applicable:Ongoing: Atherosclerosis(1) Cardiovascular Diseases(1) Phase Not Applicable:Finished: Syndrome(1) Thrombocytopenia(1) Myelodysplastic Syndromes(1) Preleukemia(1) Anemia(1) Heart Failure(1) HIV Infections(1) AIDS-Related Complex(1) Mycobacterium avium-intracellulare Infection(1) Mycobacterium Infections(1) Communicable Diseases(1) (skip...) Phase Not Applicable:Aborted: Heart Failure(1) |
ALL | 19 | 14 | 35 | 6 | 16 | 1 | 1 | 6 |
| 2023 | 4 ⬤ | 3 ⬤ | 13 ⬤ | 2 ⬤ | - | - | - | 2 ⬤ | |||
| 2022 | 7 ⬤ | 2 ⬤ | 6 ⬤ | 1 ⬤ | - | - | - | - | |||
| 2021 | 3 ⬤ | 4 ⬤ | 5 ⬤ | - | 1 | - | - | - | |||
|
GILD
(Gilead Sciences Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(5) Hepatitis D, Chronic(2) Hepatitis D(2) Lymphoma, B-Cell(2) Lymphoma(2) Lupus Erythematosus, Systemic(1) Arthritis, Rheumatoid(1) Arthritis(1) Hepatitis, Chronic(1) Hepatitis(1) Hepatitis B, Chronic(1) (skip...) Phase 1:Finished: Hepatitis C(12) Hepatitis(10) Hepatitis A(8) HIV Infections(8) Hepatitis C, Chronic(6) Long QT Syndrome(5) Fibrosis(5) Leukemia, Lymphocytic, Chronic, B-Cell(5) Renal Insufficiency(4) Arthritis, Rheumatoid(4) Arthritis(4) (skip...) Phase 1:Abnormal: HIV Infections(1) Phase 1:Aborted: Lymphoma(8) Leukemia(6) Neoplasms(5) Leukemia, Lymphoid(5) Leukemia, Lymphocytic, Chronic, B-Cell(4) Lymphoma, B-Cell(3) Adenocarcinoma(3) Fibrosis(3) Lymphoma, Non-Hodgkin(3) Hematologic Neoplasms(2) Lymphoma, Follicular(2) (skip...) Phase 2:Ongoing: Lymphoma(5) Neoplasms(4) Triple Negative Breast Neoplasms(3) Breast Neoplasms(3) Lymphoma, B-Cell(3) Lymphoma, Non-Hodgkin(3) HIV Infections(2) Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Hepatitis(2) Hepatitis B, Chronic(2) (skip...) Phase 2:Finished: Hepatitis C(57) Hepatitis(45) Infections(35) Hepatitis A(32) Communicable Diseases(24) Hepatitis, Chronic(17) Hepatitis B(16) Hepatitis C, Chronic(15) Hepatitis B, Chronic(13) Lymphoma(13) HIV Infections(9) (skip...) Phase 2:Abnormal: HIV Infections(1) Phase 2:Aborted: Leukemia, Lymphocytic, Chronic, B-Cell(8) Lymphoma(8) Leukemia, Lymphoid(7) Leukemia(7) Fibrosis(5) Lymphoma, Non-Hodgkin(5) Hepatitis(4) Colorectal Neoplasms(3) Hepatitis A(3) Lymphoma, Large B-Cell, Diffuse(3) Hepatitis C(3) (skip...) Phase 3:Ongoing: HIV Infections(6) Breast Neoplasms(5) Communicable Diseases(4) Infections(4) Acquired Immunodeficiency Syndrome(4) Triple Negative Breast Neoplasms(3) Lymphoma(3) COVID-19(2) Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Leukemia, Myeloid, Acute(2) (skip...) Phase 3:Finished: Hepatitis C(43) Infections(33) Hepatitis(33) HIV Infections(26) Communicable Diseases(21) Hepatitis A(19) Acquired Immunodeficiency Syndrome(13) Hepatitis B(12) Hepatitis C, Chronic(11) Immunologic Deficiency Syndromes(10) Fibrosis(9) (skip...) Phase 3:Abnormal: Lymphoma, Non-Hodgkin(2) Lymphoma(2) HIV Infections(1) Phase 3:Aborted: Leukemia, Lymphocytic, Chronic, B-Cell(4) Leukemia, Lymphoid(4) Leukemia(4) COVID-19(3) Lymphoma(3) Fibrosis(3) Hypertension(3) Spondylitis, Ankylosing(2) Spondylitis(2) Arthritis, Psoriatic(2) Arthritis(2) (skip...) Phase 4:Ongoing: Infections(1) Neoplasms(1) Phase 4:Finished: HIV Infections(12) Infections(4) Hepatitis, Chronic(3) Hepatitis(3) Hepatitis B, Chronic(3) Hepatitis B(3) Myocardial Ischemia(2) Hepatitis A(2) Angina Pectoris(2) Hepatitis C(1) Diabetes Mellitus(1) (skip...) Phase 4:Aborted: Coronary Disease(2) Myocardial Ischemia(2) Coronary Artery Disease(2) Neoplasms(1) Hepatitis(1) Hepatitis B, Chronic(1) Hepatitis B(1) Hepatitis A(1) Diabetes Mellitus(1) Angina, Stable(1) Angina Pectoris(1) (skip...) Phase Not Applicable:Finished: HIV Infections(5) Acquired Immunodeficiency Syndrome(2) Infections(2) Herpes Simplex(1) Retinitis(1) Cytomegalovirus Retinitis(1) Phase Not Applicable:Abnormal: HIV Infections(1) Retinitis(1) Cytomegalovirus Retinitis(1) Phase Not Applicable:Aborted: Hepatitis(1) Hepatitis B(1) |
ALL | 14 | 30 | 27 | 2 | 17 | - | 6 | 9 |
| 2023 | 7 ⬤ | 4 ⬤ | 3 ⬤ | 1 ⬤ | - | - | - | - | |||
| 2022 | 1 ⬤ | 6 ⬤ | 7 ⬤ | - | 2 | - | - | - | |||
| 2021 | 4 ⬤ | 13 ⬤ | 5 ⬤ | - | - | - | 1 | - | |||
|
REGN
(Regeneron Pharmaceuticals Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(4) Lymphoma(2) Non-alcoholic Fatty Liver Disease(1) Fatty Liver(1) Liver Diseases(1) Aggression(1) Lymphoma, B-Cell(1) Lymphoma, Non-Hodgkin(1) Neoplasms, Plasma Cell(1) Multiple Myeloma(1) Squamous Cell Carcinoma of Head and Neck(1) (skip...) Phase 1:Finished: Arthritis(5) Dermatitis(4) Dermatitis, Atopic(4) Arthritis, Rheumatoid(4) Macular Degeneration(4) Lymphoma(4) COVID-19(3) Melanoma(3) Neoplasms(3) Asthma(2) Eczema(2) (skip...) Phase 1:Aborted: Neoplasms(2) COVID-19(1) Carcinoma, Non-Small-Cell Lung(1) Lung Neoplasms(1) Diabetes Mellitus, Type 2(1) Diabetes Mellitus(1) Phase 2:Ongoing: Neoplasms, Plasma Cell(5) Multiple Myeloma(5) Carcinoma(4) Smoldering Multiple Myeloma(2) Lipodystrophy(2) Carcinoma, Squamous Cell(2) Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Prostatic Neoplasms(2) Squamous Cell Carcinoma of Head and Neck(2) Fallopian Tube Neoplasms(2) (skip...) Phase 2:Finished: Eczema(6) Dermatitis(6) Dermatitis, Atopic(6) Hypercholesterolemia(5) Macular Degeneration(4) Hemoglobinuria, Paroxysmal(3) Hemoglobinuria(3) Hyperlipoproteinemia Type II(3) COVID-19(2) Peanut Hypersensitivity(2) Hypersensitivity(2) (skip...) Phase 2:Abnormal: Heart Failure(1) Phase 2:Aborted: Eczema(3) Dermatitis(3) Dermatitis, Atopic(3) Osteoarthritis, Knee(3) Osteoarthritis(3) COVID-19(2) Pancreatitis(2) Carcinoma, Non-Small-Cell Lung(2) Hypertriglyceridemia(1) Hodgkin Disease(1) Lymphoma(1) (skip...) Phase 3:Ongoing: Lymphoma(4) Carcinoma, Non-Small-Cell Lung(4) Lung Neoplasms(4) Lymphoma, Follicular(3) Melanoma(3) Hemoglobinuria, Paroxysmal(2) Hemoglobinuria(2) Macular Edema(2) Eosinophilic Esophagitis(2) Carcinoma(2) Lymphoma, B-Cell, Marginal Zone(1) (skip...) Phase 3:Finished: Dermatitis(10) Hypercholesterolemia(10) Dermatitis, Atopic(9) Hyperlipoproteinemia Type II(6) (6) Eczema(5) Osteoarthritis, Knee(4) Osteoarthritis(4) Osteoarthritis, Hip(3) COVID-19(2) Homozygous Familial Hypercholesterolemia(2) (skip...) Phase 3:Aborted: COVID-19(2) Hemoglobinuria, Paroxysmal(2) Hemoglobinuria(2) Rhinitis, Allergic(1) Rhinitis(1) Ossification, Heterotopic(1) Myositis Ossificans(1) Carcinoma, Non-Small-Cell Lung(1) Lung Neoplasms(1) Low Back Pain(1) Back Pain(1) (skip...) Phase 4:Ongoing: Eczema(1) Dermatitis(1) Dermatitis, Atopic(1) Phase 4:Finished: Asthma(1) Vascular Diseases(1) Hypercholesterolemia(1) Macular Degeneration(1) (1) Phase 4:Aborted: Hypercholesterolemia(1) Hyperlipoproteinemia Type II(1) Phase Not Applicable:Ongoing: Celiac Disease(1) Phase Not Applicable:Finished: Hemorrhage(1) Phase Not Applicable:Aborted: Non-alcoholic Fatty Liver Disease(1) Fatty Liver(1) |
ALL | 16 | 28 | 24 | 1 | 7 | - | - | 1 |
| 2023 | 4 ⬤ | 3 ⬤ | 10 ⬤ | - | 1 | - | - | 1 | |||
| 2022 | 5 ⬤ | 3 ⬤ | 3 ⬤ | 1 ⬤ | - | - | - | - | |||
| 2021 | 1 ⬤ | 6 ⬤ | 2 ⬤ | - | 1 | - | - | - | |||
|
BGNE
(BeiGene Ltd.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(11) Lymphoma(3) Carcinoma, Non-Small-Cell Lung(2) Leukemia, Lymphocytic, Chronic, B-Cell(2) Lung Neoplasms(1) Breast Neoplasms(1) Leukemia, Lymphoid(1) Lymphoma, Non-Hodgkin(1) Lymphoma, Follicular(1) Leukemia(1) Neuroblastoma(1) (skip...) Phase 1:Finished: Neoplasms(8) COVID-19(1) Liver Failure(1) Hepatic Insufficiency(1) Lymphoma, B-Cell(1) Lymphoma(1) Phase 1:Aborted: Neoplasms(1) Phase 2:Ongoing: Lymphoma(9) Carcinoma(8) Neoplasms(6) Carcinoma, Squamous Cell(5) Carcinoma, Non-Small-Cell Lung(4) Lung Neoplasms(4) Esophageal Squamous Cell Carcinoma(4) Lymphoma, Large B-Cell, Diffuse(4) Lymphoma, Mantle-Cell(4) Leukemia, Lymphocytic, Chronic, B-Cell(4) Waldenstrom Macroglobulinemia(3) (skip...) Phase 2:Finished: Lymphoma(7) Carcinoma(3) Neoplasms(3) COVID-19(2) Lymphoma, B-Cell, Marginal Zone(2) Lung Neoplasms(2) Stomach Neoplasms(2) Lymphoma, Large B-Cell, Diffuse(2) Lymphoma, B-Cell(2) Small Cell Lung Carcinoma(1) Uterine Cervical Neoplasms(1) (skip...) Phase 2:Abnormal: Triple Negative Breast Neoplasms(1) Carcinoma, Ovarian Epithelial(1) Ovarian Neoplasms(1) Breast Neoplasms(1) Phase 2:Aborted: Prostatic Neoplasms(1) Neoplasms(1) Phase 3:Ongoing: Lung Neoplasms(6) Carcinoma, Non-Small-Cell Lung(5) Lymphoma(5) Carcinoma(4) Leukemia, Lymphocytic, Chronic, B-Cell(3) Leukemia, Lymphoid(3) Leukemia(3) Neoplasms(2) Esophageal Squamous Cell Carcinoma(2) Carcinoma, Squamous Cell(2) Glomerulonephritis, Membranous(1) (skip...) Phase 3:Finished: Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Esophageal Squamous Cell Carcinoma(1) Carcinoma, Squamous Cell(1) Carcinoma(1) Waldenstrom Macroglobulinemia(1) Phase 3:Aborted: Carcinoma, Hepatocellular(1) Carcinoma(1) |
ALL | 17 | 33 | 22 | - | 1 | - | - | - |
| 2023 | 6 ⬤ | 4 ⬤ | 2 ⬤ | - | - | - | - | - | |||
| 2022 | 4 ⬤ | 8 ⬤ | - | - | - | - | - | - | |||
| 2021 | 1 | 11 ⬤ | 3 ⬤ | - | - | - | - | - | |||
|
INCY
(Incyte Corp.) commercial physical/biological research or service Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Neoplasms(13) Carcinoma(5) Carcinoma, Squamous Cell(4) Myeloproliferative Disorders(3) Renal Insufficiency(2) Kidney Diseases(2) Squamous Cell Carcinoma of Head and Neck(2) Carcinoma, Renal Cell(2) Small Cell Lung Carcinoma(2) Carcinoma, Merkel Cell(2) Microsatellite Instability(1) (skip...) Phase 1:Finished: Neoplasms(9) Lymphoma(4) Renal Insufficiency(3) Lymphoma, B-Cell(3) Eczema(3) Dermatitis(3) Dermatitis, Atopic(3) Graft vs Host Disease(2) Hematologic Neoplasms(2) Kidney Diseases(1) Liver Diseases(1) (skip...) Phase 1:Aborted: Carcinoma, Non-Small-Cell Lung(2) Carcinoma(2) Mesothelioma(1) Sarcoma, Ewing(1) Sarcoma(1) Graft vs Host Disease(1) Hematologic Neoplasms(1) Nasopharyngeal Carcinoma(1) Nasopharyngeal Neoplasms(1) Cholangiocarcinoma(1) Carcinoma, Hepatocellular(1) (skip...) Phase 2:Ongoing: Neoplasms(6) Carcinoma(4) Lymphoma(4) Anemia(3) Vitiligo(2) Thrombocytosis(2) Polycythemia(2) Primary Myelofibrosis(2) Polycythemia Vera(2) Leukemia, Lymphoid(2) Leukemia(2) (skip...) Phase 2:Finished: Primary Myelofibrosis(8) Polycythemia Vera(5) Carcinoma, Non-Small-Cell Lung(4) Carcinoma(4) Myeloproliferative Disorders(4) Psoriasis(4) Thrombocytosis(4) Polycythemia(4) Hidradenitis(3) Hidradenitis Suppurativa(3) Lung Neoplasms(3) (skip...) Phase 2:Aborted: Neoplasms(10) Hematologic Neoplasms(3) Carcinoma, Non-Small-Cell Lung(3) Breast Neoplasms(3) Myeloproliferative Disorders(3) Multiple Myeloma(2) Lung Neoplasms(2) Syndrome(2) Thrombocythemia, Essential(2) Thrombocytosis(2) Carcinoma, Transitional Cell(1) (skip...) Phase 3:Ongoing: Thrombocythemia, Essential(4) Thrombocytosis(4) Polycythemia(4) Primary Myelofibrosis(4) Polycythemia Vera(4) Carcinoma(3) Vitiligo(2) Prurigo(2) Hidradenitis(2) Hidradenitis Suppurativa(2) Eczema(2) (skip...) Phase 3:Finished: Vitiligo(3) Polycythemia Vera(3) Eczema(2) Dermatitis(2) Dermatitis, Atopic(2) Carcinoma, Transitional Cell(2) Graft vs Host Disease(2) Polycythemia(2) Carcinoma(1) Melanoma(1) Myeloproliferative Disorders(1) (skip...) Phase 3:Aborted: Eczema(2) Lymphoma(2) Carcinoma, Non-Small-Cell Lung(2) Lung Neoplasms(2) Pancreatic Neoplasms(2) Lymphoma, Mantle-Cell(1) Lymphoma, B-Cell, Marginal Zone(1) Lymphoma, Follicular(1) COVID-19(1) Squamous Cell Carcinoma of Head and Neck(1) Carcinoma, Squamous Cell(1) (skip...) Phase 4:Ongoing: Eczema(1) Dermatitis(1) Dermatitis, Atopic(1) Parasomnias(1) Dyssomnias(1) |
ALL | 18 | 34 | 21 | 1 | 3 | - | - | 1 |
| 2023 | 6 ⬤ | 7 ⬤ | 4 ⬤ | 1 ⬤ | 1 | - | - | - | |||
| 2022 | 3 ⬤ | 5 ⬤ | 4 ⬤ | - | - | - | - | - | |||
| 2021 | 1 | 5 ⬤ | 4 ⬤ | - | - | - | - | 1 | |||
|
VRTX
(Vertex Pharmaceuticals Incorporated) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Renal Insufficiency(2) Cystic Fibrosis(2) Alpha 1-Antitrypsin Deficiency(2) Fibrosis(1) Phase 1:Finished: Cystic Fibrosis(15) Hepatitis C(7) Hepatitis C, Chronic(2) Hepatitis(2) Hepatitis A(2) Glomerulosclerosis, Focal Segmental(1) Acute Pain(1) Kidney Diseases(1) Fibrosis(1) Liver Diseases(1) Opioid-Related Disorders(1) (skip...) Phase 2:Ongoing: Diabetes Mellitus, Type 1(2) Diabetes Mellitus(2) Alpha 1-Antitrypsin Deficiency(1) Hypoglycemia(1) Phase 2:Finished: Fibrosis(19) Cystic Fibrosis(19) Hepatitis(13) Hepatitis C(13) Hepatitis A(13) Hepatitis C, Chronic(9) Arthritis, Rheumatoid(5) Arthritis(5) Acute Pain(4) Hepatitis, Chronic(4) Diabetic Neuropathies(1) (skip...) Phase 2:Aborted: Hepatitis(3) Hepatitis C(3) Hepatitis A(2) Fibrosis(2) Cystic Fibrosis(2) Alpha 1-Antitrypsin Deficiency(1) Epilepsies, Partial(1) Epilepsy(1) Virus Diseases(1) Hepatitis C, Chronic(1) Infections(1) (skip...) Phase 3:Ongoing: Fibrosis(10) Cystic Fibrosis(10) Hemoglobinopathies(5) Hematologic Diseases(5) Anemia, Sickle Cell(4) Genetic Diseases, Inborn(3) beta-Thalassemia(3) Thalassemia(3) Acute Pain(2) Kidney Diseases(1) Phase 3:Finished: Fibrosis(48) Cystic Fibrosis(48) Hepatitis(2) Hepatitis C(2) Hepatitis A(2) Acute Pain(1) Lung Diseases(1) Arthritis, Rheumatoid(1) Arthritis(1) Hepatitis C, Chronic(1) Phase 3:Aborted: Fibrosis(3) Cystic Fibrosis(3) Hepatitis(2) Hepatitis C(2) Wounds and Injuries(1) Spinal Cord Injuries(1) Hepatitis A(1) Hepatitis C, Chronic(1) Phase 4:Finished: Fibrosis(1) Cystic Fibrosis(1) Phase 4:Aborted: Cystic Fibrosis(1) Hepatitis(1) Hepatitis C, Chronic(1) Hepatitis C(1) Hepatitis A(1) Phase Not Applicable:Aborted: Neoplasms(1) |
ALL | 7 | 3 | 19 | - | 5 | - | 3 | - |
| 2023 | 5 ⬤ | 1 ⬤ | 3 ⬤ | - | - | - | 1 | - | |||
| 2022 | 2 ⬤ | 1 ⬤ | 9 ⬤ | - | - | - | - | - | |||
| 2021 | - | 1 ⬤ | 3 ⬤ | - | - | - | - | - | |||
|
BIIB
(Biogen Idec Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Friedreich Ataxia(1) Cerebellar Ataxia(1) Ataxia(1) Muscular Atrophy, Spinal(1) Muscular Atrophy(1) Parkinson Disease(1) Phase 1:Finished: Multiple Sclerosis(13) Sclerosis(8) Neoplasms(7) Neuralgia(5) Schizophrenia(4) Atrophy(4) Alzheimer Disease(4) Multiple Sclerosis, Relapsing-Remitting(4) Trigeminal Neuralgia(3) Muscular Atrophy, Spinal(3) Muscular Atrophy(3) (skip...) Phase 1:Aborted: Diabetes Mellitus, Type 2(3) Diabetes Mellitus(3) Renal Insufficiency, Chronic(3) Kidney Diseases(3) Renal Insufficiency(2) Leukemia, Lymphocytic, Chronic, B-Cell(2) Leukemia, Lymphoid(2) Leukemia(2) Machado-Joseph Disease(1) Spinocerebellar Degenerations(1) Spinocerebellar Ataxias(1) (skip...) Phase 2:Ongoing: Sclerosis(2) Diabetic Neuropathies(1) Neuralgia(1) Multiple Sclerosis(1) Ischemia(1) Cerebral Infarction(1) Ischemic Stroke(1) Stroke(1) Cognitive Dysfunction(1) Dementia(1) Alzheimer Disease(1) (skip...) Phase 2:Finished: Multiple Sclerosis(15) Sclerosis(14) Multiple Sclerosis, Relapsing-Remitting(9) Kidney Diseases(5) Stroke(4) Renal Insufficiency, Chronic(4) Radiculopathy(3) Neuralgia(3) (3) Parkinson Disease(3) Arthritis, Rheumatoid(3) (skip...) Phase 2:Aborted: Arthritis, Rheumatoid(7) Arthritis(7) Sclerosis(4) Multiple Sclerosis(4) Diabetes Mellitus(3) Alzheimer Disease(2) Cognitive Dysfunction(2) Diabetes Mellitus, Type 2(2) Lupus Nephritis(2) Nephritis(2) Renal Insufficiency(2) (skip...) Phase 3:Ongoing: Lupus Erythematosus, Systemic(5) Sclerosis(4) Multiple Sclerosis(4) Atrophy(3) Muscular Atrophy, Spinal(3) Muscular Atrophy(3) Multiple Sclerosis, Relapsing-Remitting(3) Lupus Erythematosus, Discoid(2) Lupus Erythematosus, Cutaneous(2) Alzheimer Disease(2) Amyotrophic Lateral Sclerosis(1) (skip...) Phase 3:Finished: Sclerosis(27) Multiple Sclerosis(26) Multiple Sclerosis, Relapsing-Remitting(16) Crohn Disease(3) Depression(2) Depressive Disorder(2) Atrophy(2) Muscular Atrophy, Spinal(2) Muscular Atrophy(2) Depression, Postpartum(1) Depressive Disorder, Major(1) (skip...) Phase 3:Aborted: Sclerosis(10) Multiple Sclerosis(10) Multiple Sclerosis, Relapsing-Remitting(6) Lymphoma, Non-Hodgkin(3) Lymphoma(3) Depressive Disorder, Major(2) Depression(2) Depressive Disorder(2) Polycystic Kidney, Autosomal Dominant(2) Polycystic Kidney Diseases(2) Neuralgia(2) (skip...) Phase 4:Ongoing: Sclerosis(2) Multiple Sclerosis(2) Multiple Sclerosis, Relapsing-Remitting(1) Atrophy(1) Muscular Atrophy, Spinal(1) Muscular Atrophy(1) Phase 4:Finished: Multiple Sclerosis(24) Sclerosis(21) Multiple Sclerosis, Relapsing-Remitting(15) Lymphoma, Non-Hodgkin(2) Lymphoma(2) Injection Site Reaction(1) Flushing(1) Crohn Disease(1) Phase 4:Aborted: Multiple Sclerosis(9) Sclerosis(8) Multiple Sclerosis, Relapsing-Remitting(6) Erythema(1) Fatigue(1) Syndrome(1) Immune Reconstitution Inflammatory Syndrome(1) Leukoencephalopathies(1) Leukoencephalopathy, Progressive Multifocal(1) Crohn Disease(1) Phase Not Applicable:Ongoing: Atrophy(2) Muscular Atrophy, Spinal(2) Muscular Atrophy(2) Neuromuscular Diseases(1) Phase Not Applicable:Finished: Sclerosis(1) Multiple Sclerosis(1) |
ALL | 4 | 8 | 17 | 3 | 8 | 1 | - | 1 |
| 2023 | 1 ⬤ | 2 ⬤ | 1 ⬤ | - | 1 | - | - | 1 ⬤ | |||
| 2022 | 1 ⬤ | 3 ⬤ | 4 ⬤ | 2 ⬤ | - | - | - | - | |||
| 2021 | - | - | 5 ⬤ | - | 1 | - | - | - | |||
|
IONS
(Ionis Pharmaceuticals Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Pelizaeus-Merzbacher Disease(1) Neoplasms, Plasma Cell(1) Multiple Myeloma(1) Atrophy(1) Shy-Drager Syndrome(1) Multiple System Atrophy(1) Phase 1:Finished: Diabetes Mellitus, Type 2(3) Hypertriglyceridemia(2) Neoplasms(1) Fibrosis(1) Cystic Fibrosis(1) Thalassemia(1) Cardiovascular Abnormalities(1) Hypercholesterolemia(1) Hyperlipoproteinemia Type II(1) Sclerosis(1) Amyotrophic Lateral Sclerosis(1) (skip...) Phase 2:Ongoing: Prion Diseases(1) Hypertriglyceridemia(1) Atherosclerosis(1) Cardiovascular Diseases(1) Polycythemia(1) Polycythemia Vera(1) Syndrome(1) Angelman Syndrome(1) Non-alcoholic Fatty Liver Disease(1) Fatty Liver(1) Angioedemas, Hereditary(1) (skip...) Phase 2:Finished: Diabetes Mellitus, Type 2(8) Diabetes Mellitus(7) Hypertension(4) Acromegaly(3) Kidney Failure, Chronic(2) Kidney Diseases(2) (2) Colitis, Ulcerative(2) Colitis(2) Arthritis, Rheumatoid(2) Arthritis(2) (skip...) Phase 2:Aborted: Diabetes Mellitus, Type 2(3) Diabetes Mellitus(3) Acute Disease(1) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases, Obstructive(1) Lung Diseases(1) Bronchitis, Chronic(1) Bronchitis(1) beta-Thalassemia(1) Thalassemia(1) Atrophy(1) (skip...) Phase 3:Ongoing: Hypertriglyceridemia(4) Amyloidosis(3) Angioedemas, Hereditary(2) Angioedema(2) Syndrome(2) Hyperlipoproteinemia Type I(2) Cardiomyopathies(2) Atherosclerosis(1) Cardiovascular Diseases(1) Amyloid Neuropathies(1) Polyneuropathies(1) (skip...) Phase 3:Finished: Amyloidosis(3) Amyloid Neuropathies(3) Polyneuropathies(3) Syndrome(2) Hyperlipoproteinemia Type I(2) Amyloid Neuropathies, Familial(2) Crohn Disease(2) Hypertriglyceridemia(1) Carcinoma, Non-Small-Cell Lung(1) Lung Neoplasms(1) Phase Not Applicable:Finished: Retinitis(2) Cytomegalovirus Retinitis(2) |
ALL | 3 | 8 | 13 | - | - | - | - | - |
| 2023 | 1 ⬤ | 1 ⬤ | - | - | - | - | - | - | |||
| 2022 | - | 1 | 5 ⬤ | - | - | - | - | - | |||
| 2021 | - | 3 ⬤ | 7 ⬤ | - | - | - | - | - | |||
|
ARGX
(argenx SE) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Renal Insufficiency(1) Phase 1:Finished: Nasopharyngeal Carcinoma(1) Phase 2:Ongoing: Syndrome(3) Tachycardia(2) Postural Orthostatic Tachycardia Syndrome(2) Neuritis(2) Delayed Graft Function(1) Sjogren\'s Syndrome(1) Lupus Nephritis(1) Nephritis(1) Glomerulonephritis, Membranous(1) Kidney Diseases(1) Polyradiculoneuropathy, Chronic Inflammatory Demyelinating(1) (skip...) Phase 2:Finished: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating(1) Polyneuropathies(1) Pemphigus(1) Purpura, Thrombocytopenic, Idiopathic(1) Thrombocytopenia(1) Myasthenia Gravis(1) Paresis(1) Muscle Weakness(1) Phase 3:Ongoing: Muscle Weakness(4) Myasthenia Gravis(4) Myositis(2) Pemphigoid, Bullous(2) Purpura, Thrombocytopenic, Idiopathic(2) Thrombocytopenia(2) Muscular Diseases(1) Pemphigus(1) Phase 3:Finished: Muscle Weakness(3) Myasthenia Gravis(3) Purpura, Thrombocytopenic, Idiopathic(2) Thrombocytopenia(2) Paresis(2) Pemphigus(1) Phase 3:Aborted: Purpura, Thrombocytopenic, Idiopathic(1) Thrombocytopenia(1) |
ALL | 2 | 9 | 11 | - | 1 | - | - | 1 |
| 2023 | 1 | 4 ⬤ | 1 ⬤ | - | - | - | - | 1 | |||
| 2022 | 1 ⬤ | 3 ⬤ | 4 ⬤ | - | - | - | - | - | |||
| 2021 | - | 1 | 4 ⬤ | - | 1 | - | - | - | |||
|
SBFM
(Sunshine Biopharma Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Renal Insufficiency, Chronic(3) Kidney Diseases(3) Diabetes Mellitus, Type 2(2) Sleep Initiation and Maintenance Disorders(2) Pulmonary Eosinophilia(2) Arthritis, Gouty(1) Asthma(1) Thrombocytopenia(1) Liver Diseases(1) Familial Mediterranean Fever(1) Arthritis, Juvenile(1) (skip...) Phase 1:Finished: Hepatitis C, Chronic(6) Hepatitis C(6) Idiopathic Pulmonary Fibrosis(4) Pulmonary Fibrosis(4) Non-alcoholic Fatty Liver Disease(3) Fatty Liver(3) Hepatitis B, Chronic(3) Hepatitis B(3) Depressive Disorder, Major(2) Depressive Disorder(2) Neoplasms(2) (skip...) Phase 1:Abnormal: Colorectal Neoplasms(1) Kidney Failure, Chronic(1) Phase 1:Aborted: Pancreatic Neoplasms(1) Leukemia, Myeloid, Acute(1) Leukemia, Myeloid(1) Leukemia(1) Phase 2:Ongoing: Lung Diseases(2) Sarcoma(2) Pulmonary Fibrosis(2) Retinal Vein Occlusion(2) Carcinoma, Non-Small-Cell Lung(2) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases, Obstructive(1) Polyps(1) Nasal Polyps(1) Sinusitis(1) Psoriasis(1) (skip...) Phase 2:Finished: Hepatitis C(2) Dermatitis(1) Dermatitis, Atopic(1) Hepatitis C, Chronic(1) Esophageal Squamous Cell Carcinoma(1) Carcinoma, Squamous Cell(1) Carcinoma(1) Hepatitis, Chronic(1) Hepatitis(1) Hepatitis B, Chronic(1) Hepatitis B(1) (skip...) Phase 2:Abnormal: Hepatitis(1) Hepatitis B, Chronic(1) Hepatitis B(1) Hepatitis A(1) Phase 2:Aborted: Carcinoma, Renal Cell(1) Phase 3:Ongoing: Diabetes Mellitus(1) Leukemia, Myeloid, Acute(1) Leukemia(1) Psoriasis(1) Retinal Vein Occlusion(1) Hepatitis C(1) Infections(1) Kidney Failure, Chronic(1) Renal Insufficiency(1) Depressive Disorder, Major(1) Depression(1) (skip...) Phase 3:Finished: Spondylitis, Ankylosing(1) Spondylitis(1) Hepatitis C(1) Infections(1) Anemia(1) Phase 4:Ongoing: Fibrosis(1) Bronchiectasis(1) Cystic Fibrosis(1) Burkholderia Infections(1) HIV Infections(1) Phase 4:Finished: Purpura, Thrombocytopenic, Idiopathic(1) Thrombocytopenia(1) Phase 4:Aborted: Anemia(1) Phase Not Applicable:Finished: Genetic Diseases, X-Linked(1) Parkinsonian Disorders(1) Dystonic Disorders(1) Dystonia(1) |
ALL | 28 | 21 | 9 | 2 | - | - | - | 31 |
| 2023 | 2 | 2 ⬤ | 1 | 1 ⬤ | - | - | - | 1 ⬤ | |||
| 2022 | 3 | 6 | 5 | 1 | - | - | - | 3 | |||
| 2021 | 11 | 7 | 2 | - | - | - | - | 5 | |||
|
SGEN
(Seagen Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Carcinoma(8) Neoplasms(7) Carcinoma, Non-Small-Cell Lung(6) Colorectal Neoplasms(4) Breast Neoplasms(4) Adenocarcinoma(3) Stomach Neoplasms(2) Esophageal Squamous Cell Carcinoma(2) Carcinoma, Squamous Cell(2) Squamous Cell Carcinoma of Head and Neck(2) Lymphoma, Large B-Cell, Diffuse(2) (skip...) Phase 1:Finished: Lymphoma(11) Lymphoma, Non-Hodgkin(6) Hodgkin Disease(4) Lymphoma, Large-Cell, Anaplastic(4) Leukemia(4) Breast Neoplasms(3) Neoplasms(3) Lymphoma, Large B-Cell, Diffuse(3) Leukemia, Myeloid, Acute(3) Leukemia, Myeloid(3) Lymphoma, Mantle-Cell(2) (skip...) Phase 1:Aborted: Carcinoma(4) Neoplasms, Plasma Cell(3) Multiple Myeloma(3) Breast Neoplasms(3) Carcinoma, Non-Small-Cell Lung(3) Lymphoma(3) Neoplasms(2) Lymphoma, Non-Hodgkin(2) Immunologic Deficiency Syndromes(1) HIV Infections(1) Acquired Immunodeficiency Syndrome(1) (skip...) Phase 2:Ongoing: Carcinoma, Non-Small-Cell Lung(5) Carcinoma(5) Breast Neoplasms(4) Neoplasms(3) Carcinoma, Squamous Cell(3) Adenocarcinoma(2) Uterine Cervical Neoplasms(2) Lymphoma(2) Squamous Cell Carcinoma of Head and Neck(2) Colorectal Neoplasms(2) Triple Negative Breast Neoplasms(2) (skip...) Phase 2:Finished: Lymphoma(11) Lymphoma, Non-Hodgkin(6) Hodgkin Disease(6) Uterine Cervical Neoplasms(4) Lymphoma, Large-Cell, Anaplastic(4) Ovarian Neoplasms(3) Esophageal Neoplasms(3) Leukemia(3) Carcinoma, Non-Small-Cell Lung(3) Lymphoma, T-Cell(3) Lymphoma, B-Cell(3) (skip...) Phase 2:Aborted: Lymphoma(6) Lymphoma, Large B-Cell, Diffuse(5) Lymphoma, B-Cell(4) Lymphoma, Follicular(2) Lymphoma, Large-Cell, Anaplastic(1) Lymphoma, T-Cell, Peripheral(1) Lymphoma, T-Cell(1) Hodgkin Disease(1) Syndrome(1) Myelodysplastic Syndromes(1) Preleukemia(1) (skip...) Phase 3:Ongoing: Breast Neoplasms(2) Carcinoma, Non-Small-Cell Lung(1) Lung Neoplasms(1) Carcinoma, Transitional Cell(1) Carcinoma(1) Colorectal Neoplasms(1) Uterine Cervical Neoplasms(1) Esophageal Neoplasms(1) Adenocarcinoma(1) Lymphoma, Large B-Cell, Diffuse(1) Lymphoma, B-Cell(1) (skip...) Phase 3:Finished: Lymphoma(2) Lymphoma, T-Cell, Peripheral(1) Lymphoma, Large-Cell, Anaplastic(1) Lymphoma, T-Cell(1) Hodgkin Disease(1) Phase 3:Aborted: Leukemia, Myeloid, Acute(1) Leukemia, Myeloid(1) Leukemia(1) |
ALL | 11 | 14 | 8 | - | 2 | - | - | - |
| 2023 | 3 ⬤ | 2 ⬤ | 2 ⬤ | - | - | - | - | - | |||
| 2022 | 3 ⬤ | - | 1 ⬤ | - | - | - | - | - | |||
| 2021 | 1 ⬤ | 2 ⬤ | 2 ⬤ | - | 1 | - | - | - | |||
|
VNDA
(Vanda Pharmaceuticals Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Hematologic Neoplasms(1) Neoplasms(1) Phase 1:Finished: Schizophrenia(2) Pruritus(1) Renal Insufficiency(1) Liver Diseases(1) Phase 1:Abnormal: Autism Spectrum Disorder(1) Disease(1) Smith-Magenis Syndrome(1) Sleep Disorders, Circadian Rhythm(1) Sleep Wake Disorders(1) Phase 2:Ongoing: Dyspepsia(1) Mental Disorders(1) Psychotic Disorders(1) Parkinson Disease(1) Anxiety Disorders(1) Phase 2:Finished: Pruritus(2) Eczema(2) Dermatitis(2) Dermatitis, Atopic(2) Conjunctivitis, Allergic(1) Conjunctivitis(1) Motion Sickness(1) Jet Lag Syndrome(1) Sleep Disorders, Circadian Rhythm(1) Sleep Wake Disorders(1) Sleepiness(1) (skip...) Phase 2:Abnormal: Gastroparesis(1) Phase 3:Ongoing: Motion Sickness(3) Disease(2) Sleep Wake Disorders(2) Autistic Disorder(1) Nervous System Diseases(1) Dyssomnias(1) Parasomnias(1) Chronobiology Disorders(1) Sleep Disorders, Circadian Rhythm(1) Severe Acute Respiratory Syndrome(1) Coronavirus Infections(1) (skip...) Phase 3:Finished: Disease(4) Sleep Disorders, Circadian Rhythm(3) Sleep Wake Disorders(3) Sleep Initiation and Maintenance Disorders(3) Eczema(2) Dermatitis(2) Dermatitis, Atopic(2) Schizophrenia(2) Jet Lag Syndrome(1) Syndrome(1) Smith-Magenis Syndrome(1) (skip...) Phase 3:Abnormal: Disease(1) Sleep Disorders, Circadian Rhythm(1) Sleep Wake Disorders(1) Phase 4:Ongoing: Schizophrenia(1) Phase 4:Finished: Sleep Disorders, Circadian Rhythm(1) Sleep Wake Disorders(1) |
ALL | 3 | 3 | 8 | 1 | 2 | - | 1 | - |
| 2023 | - | - | 2 ⬤ | - | - | - | - | - | |||
| 2022 | 1 | 2 | - | 1 | - | - | - | - | |||
| 2021 | 1 | 1 | 2 | - | - | - | - | - | |||
|
TEVA
(Teva Pharmaceutical Industries Limited) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Finished:
Malnutrition(19) Asthma(4) Neoplasms(2) Cognitive Dysfunction(1) Parkinson Disease(1) Hematologic Neoplasms(1) Sleepiness(1) Narcolepsy(1) Rhinitis, Allergic(1) Rhinitis(1) Lymphoma, Large B-Cell, Diffuse(1) (skip...) Phase 1:Aborted: Pulmonary Disease, Chronic Obstructive(2) Lung Diseases, Obstructive(2) Depressive Disorder(1) Phase 2:Ongoing: (2) Colitis, Ulcerative(2) Colitis(2) Crohn Disease(2) Phase 2:Finished: Asthma(8) Sclerosis(7) Multiple Sclerosis(7) Leukemia(3) Glioblastoma(3) Crohn Disease(3) Headache(2) Migraine Disorders(2) Lupus Erythematosus, Systemic(2) Rhinitis, Allergic, Seasonal(2) Rhinitis, Allergic(2) (skip...) Phase 2:Aborted: Sclerosis(3) Multiple Sclerosis(3) Asthma(2) Neoplasms(2) Crohn Disease(2) Cystitis, Interstitial(1) Cystitis(1) Myofascial Pain Syndromes(1) Fibromyalgia(1) Diabetes Mellitus, Type 2(1) Diabetes Mellitus(1) (skip...) Phase 3:Ongoing: Migraine Disorders(4) Asthma(1) Schizophrenia(1) Atrophy(1) Dyspareunia(1) Chronic Urticaria(1) Urticaria(1) Phase 3:Finished: Asthma(24) Sclerosis(9) Multiple Sclerosis(9) Rhinitis, Allergic(7) Rhinitis(7) Multiple Sclerosis, Relapsing-Remitting(7) Parkinson Disease(7) Migraine Disorders(4) Pulmonary Eosinophilia(4) Rhinitis, Allergic, Perennial(4) Low Back Pain(3) (skip...) Phase 3:Abnormal: Rhinitis, Allergic, Seasonal(1) Rhinitis, Allergic(1) Rhinitis(1) Phase 3:Aborted: Sclerosis(4) Multiple Sclerosis(4) Headache(3) Cluster Headache(3) Asthma(3) Multiple Sclerosis, Relapsing-Remitting(2) Pulmonary Eosinophilia(2) Disease Progression(2) Cerebral Palsy(1) Syndrome(1) Tourette Syndrome(1) (skip...) Phase 4:Finished: Multiple Sclerosis(6) Sclerosis(5) Asthma(3) Parkinson Disease(3) Multiple Sclerosis, Relapsing-Remitting(2) Depressive Disorder, Major(1) Depression(1) Depressive Disorder(1) Migraine Disorders(1) Dwarfism, Pituitary(1) Lung Diseases(1) (skip...) Phase 4:Aborted: Sclerosis(2) Multiple Sclerosis, Relapsing-Remitting(2) Multiple Sclerosis(2) Asthma(2) Inflammation(1) |
ALL | - | 2 | 8 | - | 17 | 4 | 29 | 911 |
| 2023 | - | - | 2 ⬤ | - | - | - | - | 14 ⬤ | |||
| 2022 | - | 2 ⬤ | 2 ⬤ | - | - | 1 | - | 31 | |||
| 2021 | - | - | 1 | - | - | - | - | 23 | |||
|
RARE
(Ultragenyx Pharmaceutical Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Finished:
Distal Myopathies(1) Muscular Diseases(1) Phase 2:Ongoing: Hepatolenticular Degeneration(1) Syndrome(1) Angelman Syndrome(1) Phase 2:Finished: Syndrome(2) Mucopolysaccharidoses(2) Distal Myopathies(2) Muscular Diseases(2) Osteogenesis Imperfecta(2) Glycogen Storage Disease(1) Mucopolysaccharidosis VII(1) Carbohydrate Metabolism, Inborn Errors(1) Disease(1) Hypophosphatasia(1) Bone Diseases, Metabolic(1) (skip...) Phase 2:Aborted: Osteogenesis Imperfecta(2) Disease(1) Glycogen Storage Disease Type III(1) Glycogen Storage Disease(1) Mucopolysaccharidosis III(1) Mucopolysaccharidoses(1) Distal Myopathies(1) Muscular Diseases(1) Hemophilia B(1) Hemophilia A(1) Syndrome(1) (skip...) Phase 3:Ongoing: Osteogenesis Imperfecta(2) Mucopolysaccharidosis III(2) Mucopolysaccharidoses(2) Ornithine Carbamoyltransferase Deficiency Disease(1) Disease(1) Metabolic Diseases(1) Glycogen Storage Disease Type I(1) Glycogen Storage Disease(1) Phase 3:Finished: Mucopolysaccharidosis VII(2) Mucopolysaccharidoses(2) Syndrome(1) Distal Myopathies(1) Muscular Diseases(1) Phase 3:Aborted: Syndrome(1) Carbohydrate Metabolism, Inborn Errors(1) Movement Disorders(1) Distal Myopathies(1) Muscular Diseases(1) |
ALL | - | 2 | 7 | - | 2 | - | - | - |
| 2023 | - | - | 2 ⬤ | - | - | - | - | - | |||
| 2022 | - | - | 1 ⬤ | - | - | - | - | - | |||
| 2021 | - | 1 ⬤ | 2 ⬤ | - | - | - | - | - | |||
|
NVAX
(Novavax Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Finished:
Influenza, Human(3) Hemorrhagic Fever, Ebola(1) Influenza in Birds(1) Respiratory Syncytial Virus Infections(1) Phase 2:Ongoing: Influenza, Human(1) COVID-19(1) Phase 2:Finished: Influenza, Human(9) COVID-19(3) Respiratory Syncytial Virus Infections(2) Severe Acute Respiratory Syndrome(1) Influenza in Birds(1) Phase 2:Aborted: COVID-19(1) Influenza, Human(1) Phase 3:Ongoing: COVID-19(7) Severe Acute Respiratory Syndrome(1) Phase 3:Finished: COVID-19(2) Influenza, Human(1) Respiratory Syncytial Virus Infections(1) |
ALL | - | 1 | 7 | - | - | - | - | - |
| 2023 | - | - | 4 ⬤ | - | - | - | - | - | |||
| 2022 | - | 1 | 2 | - | - | - | - | - | |||
| 2021 | - | - | - | - | - | - | - | - | |||
|
AXSM
(Axsome Therapeutics Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Finished:
Sleepiness(1) Disorders of Excessive Somnolence(1) Narcolepsy(1) Sleep Apnea, Obstructive(1) Phase 2:Ongoing: Depressive Disorder, Treatment-Resistant(1) Depressive Disorder, Major(1) Depressive Disorder(1) Depression(1) Phase 2:Finished: Depressive Disorder, Major(3) Depression(3) Depressive Disorder(3) Depressive Disorder, Treatment-Resistant(2) Sleepiness(1) Cataplexy(1) Narcolepsy(1) Phase 3:Ongoing: Sleepiness(2) Cataplexy(2) Disorders of Excessive Somnolence(2) Narcolepsy(2) Psychomotor Agitation(2) Dementia(2) Alzheimer Disease(2) Migraine Disorders(1) Osteoarthritis, Knee(1) Osteoarthritis(1) Phase 3:Finished: Migraine Disorders(3) Depressive Disorder, Major(3) Depression(3) Depressive Disorder(3) Psychomotor Agitation(2) Dementia(2) Alzheimer Disease(2) Disease(2) Depressive Disorder, Treatment-Resistant(1) Phase 3:Abnormal: Syndrome(1) Reflex Sympathetic Dystrophy(1) Complex Regional Pain Syndromes(1) Phase 4:Finished: Sleepiness(1) Disorders of Excessive Somnolence(1) Sleep Apnea, Obstructive(1) Sleep Apnea Syndromes(1) (1) |
ALL | - | 1 | 7 | - | 1 | - | 1 | - |
| 2023 | - | - | 1 ⬤ | - | - | - | - | - | |||
| 2022 | - | - | 2 ⬤ | - | - | - | 1 | - | |||
| 2021 | - | 1 | 3 ⬤ | - | - | - | - | - | |||
|
KRTX
(Karuna Therapeutics Inc.) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Finished:
Schizophrenia(1) Phase 2:Finished: Schizophrenia(1) Phase 3:Ongoing: Schizophrenia(4) Mental Disorders(3) Psychotic Disorders(3) Alzheimer Disease(3) Phase 3:Finished: Schizophrenia(3) Phase 3:Aborted: Schizophrenia(1) Phase Not Applicable:Finished: Chronic Pain(1) Low Back Pain(1) Shoulder Pain(1) |
ALL | - | - | 7 | - | - | - | - | - |
| 2023 | - | - | 3 ⬤ | - | - | - | - | - | |||
| 2022 | - | - | 2 ⬤ | - | - | - | - | - | |||
| 2021 | - | - | 2 ⬤ | - | - | - | - | - | |||
|
EXEL
(Exelixis Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Breast Neoplasms(3) Carcinoma, Ovarian Epithelial(2) Triple Negative Breast Neoplasms(2) Neoplasms(2) Carcinoma, Renal Cell(2) Carcinoma(2) Squamous Cell Carcinoma of Head and Neck(1) Endometrial Neoplasms(1) Phase 1:Finished: Thyroid Neoplasms(3) Thyroid Cancer, Papillary(2) Renal Insufficiency(1) Liver Diseases(1) Thyroid Diseases(1) Adenocarcinoma, Follicular(1) Carcinoma, Renal Cell(1) Gliosarcoma(1) Glioblastoma(1) Neoplasms(1) Phase 1:Abnormal: Neoplasms(1) Phase 1:Aborted: Polycythemia(2) Polycythemia Vera(2) Neoplasms(2) Leukemia, Lymphocytic, Chronic, B-Cell(2) Leukemia, Lymphoid(2) Leukemia(2) Lymphoma, Large B-Cell, Diffuse(1) Lymphoma, Mantle-Cell(1) Lymphoma, Non-Hodgkin(1) Lymphoma(1) Carcinoma, Non-Small-Cell Lung(1) (skip...) Phase 2:Ongoing: Triple Negative Breast Neoplasms(1) Endometrial Neoplasms(1) Carcinoma, Renal Cell(1) Carcinoma(1) Phase 2:Finished: Glioblastoma(2) Astrocytoma(1) Carcinoma, Non-Small-Cell Lung(1) Lung Neoplasms(1) Digestive System Neoplasms(1) Gastrointestinal Neoplasms(1) Gastrointestinal Stromal Tumors(1) Phase 2:Aborted: Prostatic Neoplasms(1) Phase 3:Ongoing: Carcinoma(4) Carcinoma, Renal Cell(2) Squamous Cell Carcinoma of Head and Neck(1) Carcinoma, Squamous Cell(1) Colorectal Neoplasms(1) Prostatic Neoplasms(1) Carcinoma, Hepatocellular(1) Thyroid Diseases(1) Thyroid Neoplasms(1) Phase 3:Finished: Carcinoma(2) Carcinoma, Hepatocellular(1) Carcinoma, Renal Cell(1) Prostatic Neoplasms(1) Thyroid Diseases(1) Thyroid Neoplasms(1) Phase 3:Aborted: Prostatic Neoplasms(1) Phase 4:Ongoing: Thyroid Diseases(1) Carcinoma, Neuroendocrine(1) Thyroid Neoplasms(1) |
ALL | 4 | 1 | 7 | 1 | 1 | - | 1 | - |
| 2023 | - | - | 1 ⬤ | - | - | - | - | - | |||
| 2022 | - | - | 2 ⬤ | - | - | - | - | - | |||
| 2021 | 3 ⬤ | - | - | - | - | - | - | - | |||
|
NBIX
(Neurocrine Biosciences Inc.) biological products (diagnostic and non diagnostic) Insider Trading Institutional Holding |
|
Phase 1:Finished:
Parkinson Disease(3) Central Nervous System Diseases(1) Brain Diseases(1) Neurodegenerative Diseases(1) Movement Disorders(1) Nervous System Diseases(1) Schizophrenia(1) Depressive Disorder(1) Syndrome(1) Tourette Syndrome(1) Liver Failure(1) (skip...) Phase 1:Aborted: Schizophrenia(1) Cerebellar Ataxia(1) Ataxia(1) Hyperplasia(1) Adrenocortical Hyperfunction(1) Adrenogenital Syndrome(1) Adrenal Hyperplasia, Congenital(1) Phase 2:Ongoing: Epilepsy(4) Brain Diseases(3) Schizophrenia(2) Syndrome(2) Seizures(1) Depressive Disorder, Major(1) Depression(1) Depressive Disorder(1) Disease(1) Cognitive Dysfunction(1) Parkinson Disease(1) (skip...) Phase 2:Finished: Syndrome(5) Tourette Syndrome(5) Schizophrenia(5) Tardive Dyskinesia(4) Dyskinesias(4) Epilepsy(2) Hyperplasia(2) Adrenocortical Hyperfunction(2) Adrenogenital Syndrome(2) Adrenal Hyperplasia, Congenital(2) Anhedonia(2) (skip...) Phase 2:Aborted: Syndrome(2) Tourette Syndrome(2) Phase 3:Ongoing: Schizophrenia(2) Hyperplasia(2) Adrenocortical Hyperfunction(2) Adrenogenital Syndrome(2) Adrenal Hyperplasia, Congenital(2) Dyskinesias(1) Cerebral Palsy(1) Paralysis(1) Chorea(1) Huntington Disease(1) Phase 3:Finished: Tardive Dyskinesia(3) Dyskinesias(3) Chorea(1) Huntington Disease(1) Phase 3:Aborted: Sleep Initiation and Maintenance Disorders(2) Depressive Disorder(1) Depression(1) Phase 4:Ongoing: Bipolar Disorder(1) Depressive Disorder, Major(1) Depressive Disorder(1) Schizophrenia(1) Tardive Dyskinesia(1) Dyskinesias(1) Phase 4:Finished: Tardive Dyskinesia(2) Dyskinesias(2) Substance Withdrawal Syndrome(1) |
ALL | - | 8 | 6 | 1 | 2 | - | - | - |
| 2023 | - | - | - | 1 ⬤ | - | - | - | - | |||
| 2022 | - | 4 ⬤ | 2 | - | - | - | - | - | |||
| 2021 | - | 3 | 2 ⬤ | - | - | - | - | - | |||
|
UTHR
(United Therapeutics Corporation) pharmaceuticals Insider Trading Institutional Holding |
|
Phase 1:Ongoing:
Hypertension(1) Familial Primary Pulmonary Hypertension(1) Pulmonary Arterial Hypertension(1) Phase 1:Finished: Hypertension(6) Hypertension, Pulmonary(2) Renal Insufficiency(1) Sclerosis(1) Scleroderma, Diffuse(1) Scleroderma, Systemic(1) Phase 1:Aborted: Bronchopulmonary Dysplasia(1) Hypertension(1) Familial Primary Pulmonary Hypertension(1) Phase 2:Finished: Hypertension(6) Familial Primary Pulmonary Hypertension(4) Hypertension, Pulmonary(2) Pulmonary Arterial Hypertension(1) Persistent Fetal Circulation Syndrome(1) Neuroblastoma(1) Scleroderma, Localized(1) Scleroderma, Diffuse(1) Scleroderma, Systemic(1) Phase 2:Abnormal: Hepatitis(1) Hepatitis C(1) Hepatitis A(1) Phase 2:Aborted: Hypertension(3) Hypertension, Pulmonary(2) Familial Primary Pulmonary Hypertension(1) Pulmonary Disease, Chronic Obstructive(1) Lung Diseases, Obstructive(1) Lung Diseases(1) Fibrosis(1) Pulmonary Fibrosis(1) Neuroblastoma(1) Sclerosis(1) Scleroderma, Diffuse(1) (skip...) Phase 3:Ongoing: Lung Diseases(6) Fibrosis(4) Lung Diseases, Interstitial(4) Pulmonary Fibrosis(4) Idiopathic Pulmonary Fibrosis(3) Hypertension(2) Familial Primary Pulmonary Hypertension(2) Respiratory Tract Diseases(2) Pulmonary Arterial Hypertension(2) Hypertension, Pulmonary(2) Phase 3:Finished: Hypertension(10) Hypertension, Pulmonary(6) Familial Primary Pulmonary Hypertension(4) Small Cell Lung Carcinoma(1) Lung Neoplasms(1) Emphysema(1) Lung Diseases, Interstitial(1) Pulmonary Fibrosis(1) Lung Diseases(1) Pulmonary Arterial Hypertension(1) Phase 3:Aborted: Hypertension(11) Hypertension, Pulmonary(8) Lung Diseases(4) Familial Primary Pulmonary Hypertension(4) Pulmonary Disease, Chronic Obstructive(2) Lung Diseases, Obstructive(2) Ischemia(2) Peripheral Arterial Disease(2) Peripheral Vascular Diseases(2) Vascular Diseases(2) Respiratory Tract Diseases(1) (skip...) Phase 4:Ongoing: Ventricular Remodeling(1) Hypertension(1) Familial Primary Pulmonary Hypertension(1) Pulmonary Arterial Hypertension(1) Phase 4:Finished: Hypertension(6) Familial Primary Pulmonary Hypertension(5) Hypertension, Pulmonary(2) Pulmonary Arterial Hypertension(1) Phase 4:Aborted: Hypertension(6) Familial Primary Pulmonary Hypertension(4) Hypertension, Pulmonary(2) |
ALL | 1 | - | 6 | 1 | 2 | - | 2 | 2 |
| 2023 | - | - | 1 ⬤ | - | - | - | - | - | |||
| 2022 | - | - | 1 ⬤ | 1 ⬤ | - | - | - | 1 | |||
| 2021 | - | - | 2 ⬤ | - | - | - | - | - |
(Continued) Drugs Marketing/Approval Status in USA, Europe, Canada
| Symbol | SMA (50w/20w/10w/5w / 50d/20d/10d/5d) | Year | United States | Europe | Canada | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human | Animal | Bioproduct | Human | Animal | Human | Animal | ||||||||||
| Marketed | Tentative Approval | Marketed | Tentative Approval | Marketed | Tentative Approval | Marketed | Positive | Marketed | Positive | Marketed | Approved | Marketed | Approved | |||
|
AZN
(AstraZeneca PLC) pharmaceuticals Insider Trading Institutional Holding |
|
ALL | 43 | - | - | - | - | - | 32 | 1 | - | - | 43 | 2 | - | - |
| 2023 | 4 ⬤ | - | - | - | - | - | 1 | 1 ⬤ | - | - | 2 | - | - | - | ||
| 2022 | 3 | - | - | - | - | - | 5 | - | - | - | 2 | - | - | - | ||
| 2021 | 2 | - | - | - | - | - | 2 | - | - | - | 3 | - | - | - | ||
|
MRK
(Merck & Company Inc.) pharmaceuticals Insider Trading Institutional Holding |
|